SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

MediXall Group, Inc. – ‘10-Q’ for 6/30/22 – ‘XML’

On:  Tuesday, 8/23/22, at 4:45pm ET   ·   For:  6/30/22   ·   Accession #:  1553350-22-715   ·   File #:  333-194337

Previous ‘10-Q’:  ‘10-Q’ on 8/1/22 for 3/31/22   ·   Next & Latest:  ‘10-Q’ on 11/14/22 for 9/30/22

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/23/22  MediXall Group, Inc.              10-Q        6/30/22   47:2.7M                                   Edgar Filing LLC/FA

Quarterly Report   —   Form 10-Q

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    560K 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     17K 
 3: EX-31.2     Certification -- §302 - SOA'02                      HTML     17K 
 4: EX-32.1     Certification -- §906 - SOA'02                      HTML     15K 
 5: EX-32.2     Certification -- §906 - SOA'02                      HTML     14K 
11: R1          Cover                                               HTML     64K 
12: R2          Condensed Consolidated Balance Sheets (Unaudited)   HTML    103K 
13: R3          Condensed Consolidated Balance Sheets (Unaudited)   HTML     37K 
                (Parenthetical)                                                  
14: R4          Condensed Consolidated Statements of Operations     HTML     88K 
                (Unaudited)                                                      
15: R5          Consolidated Statements of Changes in               HTML     68K 
                Stockholders' Equity (Deficit) (Unaudited)                       
16: R6          Consolidated Statements of Changes in               HTML     17K 
                Stockholders' Equity (Deficit) (Unaudited)                       
                (Parenthetical)                                                  
17: R7          Condensed Consolidated Statements of Cash Flows     HTML     84K 
                (Unaudited)                                                      
18: R8          Organization and Nature of Operation                HTML     20K 
19: R9          Asset Acquisition                                   HTML     19K 
20: R10         Going Concern                                       HTML     21K 
21: R11         Summary of Significant Accounting Policies          HTML     71K 
22: R12         Right-to-use Intellectual Property                  HTML     30K 
23: R13         Preferred Stock                                     HTML     25K 
24: R14         Related Party Transactions                          HTML     35K 
25: R15         Senior Convertible Debentures and Warrants          HTML     31K 
26: R16         Summary of Significant Accounting Policies          HTML    106K 
                (Policies)                                                       
27: R17         Summary of Significant Accounting Policies          HTML     49K 
                (Tables)                                                         
28: R18         Right-to-use Intellectual Property (Tables)         HTML     30K 
29: R19         Related Party Transactions (Tables)                 HTML     26K 
30: R20         Senior Convertible Debentures and Warrants          HTML     25K 
                (Tables)                                                         
31: R21         Asset Acquisition (Details Narrative)               HTML     22K 
32: R22         Going Concern (Details Narrative)                   HTML     23K 
33: R23         Summary of Significant Accounting Policies          HTML     28K 
                (Schedule of Basic and Diluted EPS) (Details)                    
34: R24         Summary of Significant Accounting Policies          HTML     22K 
                (Schedule of potentially dilutive securities)                    
                (Details)                                                        
35: R25         Summary of Significant Accounting Policies          HTML     20K 
                (Details Narrative)                                              
36: R26         Right-to-use Intellectual Property (Schedule of     HTML     22K 
                Right-to-use Intellectual Property) (Details)                    
37: R27         Right-to-use Intellectual Property (Schedule of     HTML     30K 
                amortization expense for right-to-use intellectual               
                property) (Details)                                              
38: R28         Preferred Stock (Details Narrative)                 HTML     37K 
39: R29         Related Party Transactions (Details)                HTML     32K 
40: R30         Related Party Transactions (Details Narrative)      HTML     32K 
41: R31         Senior Convertible Debentures and Warrants          HTML     31K 
                (Details)                                                        
42: R32         Senior Convertible Debentures and Warrants          HTML     42K 
                (Details Narrative)                                              
45: XML         IDEA XML File -- Filing Summary                      XML     78K 
43: XML         XBRL Instance -- mdxl_10q_htm                        XML    587K 
44: EXCEL       IDEA Workbook of Financial Reports                  XLSX     71K 
 7: EX-101.CAL  XBRL Calculations -- mdxl-20220630_cal               XML    106K 
 8: EX-101.DEF  XBRL Definitions -- mdxl-20220630_def                XML    225K 
 9: EX-101.LAB  XBRL Labels -- mdxl-20220630_lab                     XML    491K 
10: EX-101.PRE  XBRL Presentations -- mdxl-20220630_pre              XML    396K 
 6: EX-101.SCH  XBRL Schema -- mdxl-20220630                         XSD     85K 
46: JSON        XBRL Instance as JSON Data -- MetaLinks              205±   289K 
47: ZIP         XBRL Zipped Folder -- 0001553350-22-000715-xbrl      Zip    129K

‘XML’   —   XBRL Instance — mdxl_10q_htm

This Document is an XBRL XML File.

                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<xbrl xmlns="http://www.xbrl.org/2003/instance" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:mdxl="http://medixall.com/20220630" xmlns:srt="http://fasb.org/srt/2022" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<link:schemaRef xlink:href="mdxl-20220630.xsd" xlink:type="simple"/>
<context id="From2022-01-01to2022-06-30">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="AsOf2022-08-22">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
</entity>
<period>
<instant> 2022-08-22 </instant>
</period>
</context>
<context id="AsOf2022-06-30">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="AsOf2021-12-31">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="AsOf2022-06-30_us-gaap_SeriesAPreferredStockMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis"> us-gaap:SeriesAPreferredStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="AsOf2021-12-31_us-gaap_SeriesAPreferredStockMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis"> us-gaap:SeriesAPreferredStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="AsOf2022-06-30_us-gaap_SeriesBPreferredStockMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis"> us-gaap:SeriesBPreferredStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="AsOf2021-12-31_us-gaap_SeriesBPreferredStockMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis"> us-gaap:SeriesBPreferredStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="From2022-04-012022-06-30">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
</entity>
<period>
<startDate> 2022-04-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="From2021-04-012021-06-30">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
</entity>
<period>
<startDate> 2021-04-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="From2021-01-012021-06-30">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="AsOf2020-12-31_custom_SeriesAVotingPreferredStockMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> mdxl:SeriesAVotingPreferredStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2020-12-31 </instant>
</period>
</context>
<context id="AsOf2020-12-31_custom_SeriesBVotingPreferredStockMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> mdxl:SeriesBVotingPreferredStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2020-12-31 </instant>
</period>
</context>
<context id="AsOf2020-12-31_us-gaap_CommonStockMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:CommonStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2020-12-31 </instant>
</period>
</context>
<context id="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:AdditionalPaidInCapitalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2020-12-31 </instant>
</period>
</context>
<context id="AsOf2020-12-31_us-gaap_RetainedEarningsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:RetainedEarningsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2020-12-31 </instant>
</period>
</context>
<context id="AsOf2020-12-31">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
</entity>
<period>
<instant> 2020-12-31 </instant>
</period>
</context>
<context id="AsOf2021-03-31_custom_SeriesAVotingPreferredStockMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> mdxl:SeriesAVotingPreferredStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-03-31 </instant>
</period>
</context>
<context id="AsOf2021-03-31_custom_SeriesBVotingPreferredStockMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> mdxl:SeriesBVotingPreferredStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-03-31 </instant>
</period>
</context>
<context id="AsOf2021-03-31_us-gaap_CommonStockMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:CommonStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-03-31 </instant>
</period>
</context>
<context id="AsOf2021-03-31_us-gaap_AdditionalPaidInCapitalMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:AdditionalPaidInCapitalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-03-31 </instant>
</period>
</context>
<context id="AsOf2021-03-31_us-gaap_RetainedEarningsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:RetainedEarningsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-03-31 </instant>
</period>
</context>
<context id="AsOf2021-03-31">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
</entity>
<period>
<instant> 2021-03-31 </instant>
</period>
</context>
<context id="AsOf2021-12-31_custom_SeriesAVotingPreferredStockMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> mdxl:SeriesAVotingPreferredStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="AsOf2021-12-31_custom_SeriesBVotingPreferredStockMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> mdxl:SeriesBVotingPreferredStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="AsOf2021-12-31_us-gaap_CommonStockMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:CommonStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:AdditionalPaidInCapitalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="AsOf2021-12-31_us-gaap_RetainedEarningsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:RetainedEarningsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="AsOf2022-03-31_custom_SeriesAVotingPreferredStockMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> mdxl:SeriesAVotingPreferredStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-03-31 </instant>
</period>
</context>
<context id="AsOf2022-03-31_custom_SeriesBVotingPreferredStockMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> mdxl:SeriesBVotingPreferredStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-03-31 </instant>
</period>
</context>
<context id="AsOf2022-03-31_us-gaap_CommonStockMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:CommonStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-03-31 </instant>
</period>
</context>
<context id="AsOf2022-03-31_us-gaap_AdditionalPaidInCapitalMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:AdditionalPaidInCapitalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-03-31 </instant>
</period>
</context>
<context id="AsOf2022-03-31_us-gaap_RetainedEarningsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:RetainedEarningsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-03-31 </instant>
</period>
</context>
<context id="AsOf2022-03-31">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
</entity>
<period>
<instant> 2022-03-31 </instant>
</period>
</context>
<context id="From2021-01-012021-03-31_custom_SeriesAVotingPreferredStockMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> mdxl:SeriesAVotingPreferredStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-03-31 </endDate>
</period>
</context>
<context id="From2021-01-012021-03-31_custom_SeriesBVotingPreferredStockMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> mdxl:SeriesBVotingPreferredStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-03-31 </endDate>
</period>
</context>
<context id="From2021-01-012021-03-31_us-gaap_CommonStockMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:CommonStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-03-31 </endDate>
</period>
</context>
<context id="From2021-01-012021-03-31_us-gaap_AdditionalPaidInCapitalMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:AdditionalPaidInCapitalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-03-31 </endDate>
</period>
</context>
<context id="From2021-01-012021-03-31_us-gaap_RetainedEarningsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:RetainedEarningsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-03-31 </endDate>
</period>
</context>
<context id="From2021-01-012021-03-31">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-03-31 </endDate>
</period>
</context>
<context id="From2021-04-012021-06-30_custom_SeriesAVotingPreferredStockMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> mdxl:SeriesAVotingPreferredStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-04-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="From2021-04-012021-06-30_custom_SeriesBVotingPreferredStockMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> mdxl:SeriesBVotingPreferredStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-04-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="From2021-04-012021-06-30_us-gaap_CommonStockMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:CommonStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-04-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="From2021-04-012021-06-30_us-gaap_AdditionalPaidInCapitalMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:AdditionalPaidInCapitalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-04-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="From2021-04-012021-06-30_us-gaap_RetainedEarningsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:RetainedEarningsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-04-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="From2022-01-012022-03-31_custom_SeriesAVotingPreferredStockMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> mdxl:SeriesAVotingPreferredStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-03-31 </endDate>
</period>
</context>
<context id="From2022-01-012022-03-31_custom_SeriesBVotingPreferredStockMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> mdxl:SeriesBVotingPreferredStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-03-31 </endDate>
</period>
</context>
<context id="From2022-01-012022-03-31_us-gaap_CommonStockMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:CommonStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-03-31 </endDate>
</period>
</context>
<context id="From2022-01-012022-03-31_us-gaap_AdditionalPaidInCapitalMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:AdditionalPaidInCapitalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-03-31 </endDate>
</period>
</context>
<context id="From2022-01-012022-03-31_us-gaap_RetainedEarningsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:RetainedEarningsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-03-31 </endDate>
</period>
</context>
<context id="From2022-01-012022-03-31">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-03-31 </endDate>
</period>
</context>
<context id="From2022-04-012022-06-30_custom_SeriesAVotingPreferredStockMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> mdxl:SeriesAVotingPreferredStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-04-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="From2022-04-012022-06-30_custom_SeriesBVotingPreferredStockMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> mdxl:SeriesBVotingPreferredStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-04-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="From2022-04-012022-06-30_us-gaap_CommonStockMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:CommonStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-04-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="From2022-04-012022-06-30_us-gaap_AdditionalPaidInCapitalMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:AdditionalPaidInCapitalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-04-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="From2022-04-012022-06-30_us-gaap_RetainedEarningsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:RetainedEarningsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-04-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="AsOf2021-06-30_custom_SeriesAVotingPreferredStockMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> mdxl:SeriesAVotingPreferredStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-06-30 </instant>
</period>
</context>
<context id="AsOf2021-06-30_custom_SeriesBVotingPreferredStockMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> mdxl:SeriesBVotingPreferredStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-06-30 </instant>
</period>
</context>
<context id="AsOf2021-06-30_us-gaap_CommonStockMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:CommonStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-06-30 </instant>
</period>
</context>
<context id="AsOf2021-06-30_us-gaap_AdditionalPaidInCapitalMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:AdditionalPaidInCapitalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-06-30 </instant>
</period>
</context>
<context id="AsOf2021-06-30_us-gaap_RetainedEarningsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:RetainedEarningsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-06-30 </instant>
</period>
</context>
<context id="AsOf2021-06-30">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
</entity>
<period>
<instant> 2021-06-30 </instant>
</period>
</context>
<context id="AsOf2022-06-30_custom_SeriesAVotingPreferredStockMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> mdxl:SeriesAVotingPreferredStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="AsOf2022-06-30_custom_SeriesBVotingPreferredStockMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> mdxl:SeriesBVotingPreferredStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="AsOf2022-06-30_us-gaap_CommonStockMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:CommonStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="AsOf2022-06-30_us-gaap_AdditionalPaidInCapitalMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:AdditionalPaidInCapitalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="AsOf2022-06-30_us-gaap_RetainedEarningsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:RetainedEarningsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="From2022-01-012022-01-17_us-gaap_CommonStockMember_custom_MediXallGroupIncMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis"> us-gaap:CommonStockMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="dei:LegalEntityAxis"> mdxl:MediXallGroupIncMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-01-17 </endDate>
</period>
</context>
<context id="AsOf2022-01-17">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
</entity>
<period>
<instant> 2022-01-17 </instant>
</period>
</context>
<context id="From2022-01-012022-01-17_custom_MediXallGroupIncMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
<segment>
<xbrldi:explicitMember dimension="dei:LegalEntityAxis"> mdxl:MediXallGroupIncMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-01-17 </endDate>
</period>
</context>
<context id="From2022-07-012022-08-23_us-gaap_SubsequentEventMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis"> us-gaap:SubsequentEventMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-07-01 </startDate>
<endDate> 2022-08-23 </endDate>
</period>
</context>
<context id="From2022-04-012022-06-30_us-gaap_SeriesAPreferredStockMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis"> us-gaap:SeriesAPreferredStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-04-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="From2021-04-012021-06-30_us-gaap_SeriesAPreferredStockMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis"> us-gaap:SeriesAPreferredStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-04-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="From2022-01-012022-06-30_us-gaap_SeriesAPreferredStockMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis"> us-gaap:SeriesAPreferredStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="From2021-01-012021-06-30_us-gaap_SeriesAPreferredStockMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis"> us-gaap:SeriesAPreferredStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="From2022-04-012022-06-30_us-gaap_SeriesBPreferredStockMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis"> us-gaap:SeriesBPreferredStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-04-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="From2021-04-012021-06-30_us-gaap_SeriesBPreferredStockMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis"> us-gaap:SeriesBPreferredStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-04-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="From2022-01-012022-06-30_us-gaap_SeriesBPreferredStockMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis"> us-gaap:SeriesBPreferredStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="From2021-01-012021-06-30_us-gaap_SeriesBPreferredStockMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis"> us-gaap:SeriesBPreferredStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="From2022-04-012022-06-30_custom_SeniorConvertibleDebenturesAndWarrantsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis"> mdxl:SeniorConvertibleDebenturesAndWarrantsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-04-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="From2021-04-012021-06-30_custom_SeniorConvertibleDebenturesAndWarrantsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis"> mdxl:SeniorConvertibleDebenturesAndWarrantsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-04-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="From2022-01-012022-06-30_custom_SeniorConvertibleDebenturesAndWarrantsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis"> mdxl:SeniorConvertibleDebenturesAndWarrantsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="From2021-01-012021-06-30_custom_SeniorConvertibleDebenturesAndWarrantsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis"> mdxl:SeniorConvertibleDebenturesAndWarrantsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="AsOf2020-06-24_us-gaap_SeriesBPreferredStockMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis"> us-gaap:SeriesBPreferredStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2020-06-24 </instant>
</period>
</context>
<context id="From2022-01-012022-06-30_custom_TBGMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis"> mdxl:TBGMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="From2021-04-012021-04-30">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
</entity>
<period>
<startDate> 2021-04-01 </startDate>
<endDate> 2021-04-30 </endDate>
</period>
</context>
<context id="From2021-01-012021-06-30_custom_TBGMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis"> mdxl:TBGMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="AsOf2022-06-30_custom_TBGMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis"> mdxl:TBGMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="AsOf2021-06-30_custom_TBGMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis"> mdxl:TBGMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-06-30 </instant>
</period>
</context>
<context id="From2022-04-012022-06-30_custom_R3AccountingLLCMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis"> mdxl:R3AccountingLLCMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-04-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="From2022-01-012022-06-30_custom_R3AccountingLLCMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis"> mdxl:R3AccountingLLCMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="From2021-04-012021-06-30_custom_R3AccountingLLCMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis"> mdxl:R3AccountingLLCMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-04-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="From2021-01-012021-06-30_custom_R3AccountingLLCMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis"> mdxl:R3AccountingLLCMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2021-01-01 </startDate>
<endDate> 2021-06-30 </endDate>
</period>
</context>
<context id="AsOf2022-06-30_custom_TBGHoldingsCorpMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis"> mdxl:TBGHoldingsCorpMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="AsOf2021-12-31_custom_TBGHoldingsCorpMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis"> mdxl:TBGHoldingsCorpMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="AsOf2022-06-30_custom_TurnkeyMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis"> mdxl:TurnkeyMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="AsOf2021-12-31_custom_TurnkeyMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis"> mdxl:TurnkeyMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="AsOf2022-06-30_custom_R3AccountingLLCMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis"> mdxl:R3AccountingLLCMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="AsOf2021-12-31_custom_R3AccountingLLCMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis"> mdxl:R3AccountingLLCMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2021-12-31 </instant>
</period>
</context>
<context id="From2022-03-012022-03-31">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
</entity>
<period>
<startDate> 2022-03-01 </startDate>
<endDate> 2022-03-31 </endDate>
</period>
</context>
<context id="From2022-01-012022-06-30_custom_ThreeConvertibleLoanDebenturesMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis"> mdxl:ThreeConvertibleLoanDebenturesMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="AsOf2022-06-30_custom_ThreeConvertibleLoanDebenturesMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis"> mdxl:ThreeConvertibleLoanDebenturesMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="AsOf2022-06-30_srt_MinimumMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:RangeAxis"> srt:MinimumMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="AsOf2022-06-30_srt_MaximumMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:RangeAxis"> srt:MaximumMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2022-06-30 </instant>
</period>
</context>
<context id="From2022-01-012022-06-30_srt_MinimumMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:RangeAxis"> srt:MinimumMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<context id="From2022-01-012022-06-30_srt_MaximumMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001601280 </identifier>
<segment>
<xbrldi:explicitMember dimension="srt:RangeAxis"> srt:MaximumMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2022-01-01 </startDate>
<endDate> 2022-06-30 </endDate>
</period>
</context>
<unit id="USD">
<measure> iso4217:USD </measure>
</unit>
<unit id="Shares">
<measure> shares </measure>
</unit>
<unit id="USDPShares">
<divide>
<unitNumerator>
<measure> iso4217:USD </measure>
</unitNumerator>
<unitDenominator>
<measure> shares </measure>
</unitDenominator>
</divide>
</unit>
<unit id="Pure">
<measure> pure </measure>
</unit>
<dei:EntityCentralIndexKey contextRef="From2022-01-01to2022-06-30"> 0001601280 </dei:EntityCentralIndexKey>
<dei:AmendmentFlag contextRef="From2022-01-01to2022-06-30"> false </dei:AmendmentFlag>
<dei:CurrentFiscalYearEndDate contextRef="From2022-01-01to2022-06-30"> --12-31 </dei:CurrentFiscalYearEndDate>
<dei:DocumentFiscalYearFocus contextRef="From2022-01-01to2022-06-30"> 2022 </dei:DocumentFiscalYearFocus>
<dei:DocumentFiscalPeriodFocus contextRef="From2022-01-01to2022-06-30"> Q2 </dei:DocumentFiscalPeriodFocus>
<us-gaap:ConvertibleDebtCurrent contextRef="AsOf2021-12-31" id="xdx2ixbrl0092" unitRef="USD" xsi:nil="true"/>
<us-gaap:StockIssuedDuringPeriodValueOther contextRef="From2021-01-012021-03-31_custom_SeriesAVotingPreferredStockMember" id="xdx2ixbrl0278" unitRef="USD" xsi:nil="true"/>
<us-gaap:StockIssuedDuringPeriodValueOther contextRef="From2021-01-012021-03-31_custom_SeriesBVotingPreferredStockMember" id="xdx2ixbrl0279" unitRef="USD" xsi:nil="true"/>
<us-gaap:StockIssuedDuringPeriodValueOther contextRef="From2021-01-012021-03-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0282" unitRef="USD" xsi:nil="true"/>
<mdxl:ProceedsReceivedFromSaleOfPreferredStock contextRef="From2021-01-012021-03-31_custom_SeriesAVotingPreferredStockMember" id="xdx2ixbrl0289" unitRef="USD" xsi:nil="true"/>
<mdxl:ProceedsReceivedFromSaleOfPreferredStock contextRef="From2021-01-012021-03-31_us-gaap_CommonStockMember" id="xdx2ixbrl0291" unitRef="USD" xsi:nil="true"/>
<mdxl:ProceedsReceivedFromSaleOfPreferredStock contextRef="From2021-01-012021-03-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0293" unitRef="USD" xsi:nil="true"/>
<us-gaap:NetIncomeLoss contextRef="From2021-01-012021-03-31_custom_SeriesAVotingPreferredStockMember" id="xdx2ixbrl0298" unitRef="USD" xsi:nil="true"/>
<us-gaap:NetIncomeLoss contextRef="From2021-01-012021-03-31_custom_SeriesBVotingPreferredStockMember" id="xdx2ixbrl0299" unitRef="USD" xsi:nil="true"/>
<us-gaap:NetIncomeLoss contextRef="From2021-01-012021-03-31_us-gaap_CommonStockMember" id="xdx2ixbrl0300" unitRef="USD" xsi:nil="true"/>
<us-gaap:NetIncomeLoss contextRef="From2021-01-012021-03-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0301" unitRef="USD" xsi:nil="true"/>
<us-gaap:StockIssuedDuringPeriodValueOther contextRef="From2021-04-012021-06-30_custom_SeriesAVotingPreferredStockMember" id="xdx2ixbrl0318" unitRef="USD" xsi:nil="true"/>
<us-gaap:StockIssuedDuringPeriodValueOther contextRef="From2021-04-012021-06-30_custom_SeriesBVotingPreferredStockMember" id="xdx2ixbrl0319" unitRef="USD" xsi:nil="true"/>
<us-gaap:StockIssuedDuringPeriodValueOther contextRef="From2021-04-012021-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0322" unitRef="USD" xsi:nil="true"/>
<us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="From2021-04-012021-06-30_custom_SeriesAVotingPreferredStockMember" id="xdx2ixbrl0329" unitRef="USD" xsi:nil="true"/>
<us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="From2021-04-012021-06-30_custom_SeriesBVotingPreferredStockMember" id="xdx2ixbrl0330" unitRef="USD" xsi:nil="true"/>
<us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="From2021-04-012021-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0333" unitRef="USD" xsi:nil="true"/>
<us-gaap:NetIncomeLoss contextRef="From2021-04-012021-06-30_custom_SeriesAVotingPreferredStockMember" id="xdx2ixbrl0338" unitRef="USD" xsi:nil="true"/>
<us-gaap:NetIncomeLoss contextRef="From2021-04-012021-06-30_custom_SeriesBVotingPreferredStockMember" id="xdx2ixbrl0339" unitRef="USD" xsi:nil="true"/>
<us-gaap:NetIncomeLoss contextRef="From2021-04-012021-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0340" unitRef="USD" xsi:nil="true"/>
<us-gaap:NetIncomeLoss contextRef="From2021-04-012021-06-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0341" unitRef="USD" xsi:nil="true"/>
<us-gaap:StockIssuedDuringPeriodValueOther contextRef="From2022-01-012022-03-31_custom_SeriesAVotingPreferredStockMember" id="xdx2ixbrl0371" unitRef="USD" xsi:nil="true"/>
<us-gaap:StockIssuedDuringPeriodValueOther contextRef="From2022-01-012022-03-31_custom_SeriesBVotingPreferredStockMember" id="xdx2ixbrl0372" unitRef="USD" xsi:nil="true"/>
<us-gaap:StockIssuedDuringPeriodValueOther contextRef="From2022-01-012022-03-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0375" unitRef="USD" xsi:nil="true"/>
<us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="From2022-01-012022-03-31_custom_SeriesAVotingPreferredStockMember" id="xdx2ixbrl0382" unitRef="USD" xsi:nil="true"/>
<us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="From2022-01-012022-03-31_custom_SeriesBVotingPreferredStockMember" id="xdx2ixbrl0383" unitRef="USD" xsi:nil="true"/>
<us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="From2022-01-012022-03-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0386" unitRef="USD" xsi:nil="true"/>
<mdxl:CommonStockIssuedInExchangeForRighttouseIntellectualProperty contextRef="From2022-01-012022-03-31_custom_SeriesAVotingPreferredStockMember" id="xdx2ixbrl0391" unitRef="USD" xsi:nil="true"/>
<mdxl:CommonStockIssuedInExchangeForRighttouseIntellectualProperty contextRef="From2022-01-012022-03-31_custom_SeriesBVotingPreferredStockMember" id="xdx2ixbrl0392" unitRef="USD" xsi:nil="true"/>
<mdxl:CommonStockIssuedInExchangeForRighttouseIntellectualProperty contextRef="From2022-01-012022-03-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0395" unitRef="USD" xsi:nil="true"/>
<mdxl:FairValueOfWarrantsIssuedWithConvertibleDebentures contextRef="From2022-01-012022-03-31_custom_SeriesAVotingPreferredStockMember" id="xdx2ixbrl0400" unitRef="USD" xsi:nil="true"/>
<mdxl:FairValueOfWarrantsIssuedWithConvertibleDebentures contextRef="From2022-01-012022-03-31_custom_SeriesBVotingPreferredStockMember" id="xdx2ixbrl0401" unitRef="USD" xsi:nil="true"/>
<mdxl:FairValueOfWarrantsIssuedWithConvertibleDebentures contextRef="From2022-01-012022-03-31_us-gaap_CommonStockMember" id="xdx2ixbrl0402" unitRef="USD" xsi:nil="true"/>
<mdxl:FairValueOfWarrantsIssuedWithConvertibleDebentures contextRef="From2022-01-012022-03-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0404" unitRef="USD" xsi:nil="true"/>
<us-gaap:NetIncomeLoss contextRef="From2022-01-012022-03-31_custom_SeriesAVotingPreferredStockMember" id="xdx2ixbrl0407" unitRef="USD" xsi:nil="true"/>
<us-gaap:NetIncomeLoss contextRef="From2022-01-012022-03-31_custom_SeriesBVotingPreferredStockMember" id="xdx2ixbrl0408" unitRef="USD" xsi:nil="true"/>
<us-gaap:NetIncomeLoss contextRef="From2022-01-012022-03-31_us-gaap_CommonStockMember" id="xdx2ixbrl0409" unitRef="USD" xsi:nil="true"/>
<us-gaap:NetIncomeLoss contextRef="From2022-01-012022-03-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0410" unitRef="USD" xsi:nil="true"/>
<us-gaap:StockIssuedDuringPeriodValueOther contextRef="From2022-04-012022-06-30_custom_SeriesAVotingPreferredStockMember" id="xdx2ixbrl0427" unitRef="USD" xsi:nil="true"/>
<us-gaap:StockIssuedDuringPeriodValueOther contextRef="From2022-04-012022-06-30_custom_SeriesBVotingPreferredStockMember" id="xdx2ixbrl0428" unitRef="USD" xsi:nil="true"/>
<us-gaap:StockIssuedDuringPeriodValueOther contextRef="From2022-04-012022-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0431" unitRef="USD" xsi:nil="true"/>
<us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="From2022-04-012022-06-30_custom_SeriesAVotingPreferredStockMember" id="xdx2ixbrl0438" unitRef="USD" xsi:nil="true"/>
<us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="From2022-04-012022-06-30_custom_SeriesBVotingPreferredStockMember" id="xdx2ixbrl0439" unitRef="USD" xsi:nil="true"/>
<us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="From2022-04-012022-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0442" unitRef="USD" xsi:nil="true"/>
<mdxl:FairValueOfWarrantsIssuedWithConvertibleDebentures contextRef="From2022-04-012022-06-30_custom_SeriesAVotingPreferredStockMember" id="xdx2ixbrl0447" unitRef="USD" xsi:nil="true"/>
<mdxl:FairValueOfWarrantsIssuedWithConvertibleDebentures contextRef="From2022-04-012022-06-30_custom_SeriesBVotingPreferredStockMember" id="xdx2ixbrl0448" unitRef="USD" xsi:nil="true"/>
<mdxl:FairValueOfWarrantsIssuedWithConvertibleDebentures contextRef="From2022-04-012022-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0449" unitRef="USD" xsi:nil="true"/>
<mdxl:FairValueOfWarrantsIssuedWithConvertibleDebentures contextRef="From2022-04-012022-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0451" unitRef="USD" xsi:nil="true"/>
<us-gaap:NetIncomeLoss contextRef="From2022-04-012022-06-30_custom_SeriesAVotingPreferredStockMember" id="xdx2ixbrl0454" unitRef="USD" xsi:nil="true"/>
<us-gaap:NetIncomeLoss contextRef="From2022-04-012022-06-30_custom_SeriesBVotingPreferredStockMember" id="xdx2ixbrl0455" unitRef="USD" xsi:nil="true"/>
<us-gaap:NetIncomeLoss contextRef="From2022-04-012022-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0456" unitRef="USD" xsi:nil="true"/>
<us-gaap:NetIncomeLoss contextRef="From2022-04-012022-06-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0457" unitRef="USD" xsi:nil="true"/>
<dei:DocumentType contextRef="From2022-01-01to2022-06-30"> 10-Q </dei:DocumentType>
<dei:DocumentQuarterlyReport contextRef="From2022-01-01to2022-06-30"> true </dei:DocumentQuarterlyReport>
<dei:DocumentPeriodEndDate contextRef="From2022-01-01to2022-06-30"> 2022-06-30 </dei:DocumentPeriodEndDate>
<dei:DocumentTransitionReport contextRef="From2022-01-01to2022-06-30"> false </dei:DocumentTransitionReport>
<dei:EntityFileNumber contextRef="From2022-01-01to2022-06-30"> 333-194337 </dei:EntityFileNumber>
<dei:EntityRegistrantName contextRef="From2022-01-01to2022-06-30"> MediXall Group, Inc. </dei:EntityRegistrantName>
<dei:EntityIncorporationStateCountryCode contextRef="From2022-01-01to2022-06-30"> NV </dei:EntityIncorporationStateCountryCode>
<dei:EntityTaxIdentificationNumber contextRef="From2022-01-01to2022-06-30"> 33-0864127 </dei:EntityTaxIdentificationNumber>
<dei:EntityAddressAddressLine1 contextRef="From2022-01-01to2022-06-30"> 2929 East Commercial Blvd. </dei:EntityAddressAddressLine1>
<dei:EntityAddressAddressLine2 contextRef="From2022-01-01to2022-06-30"> PH-D </dei:EntityAddressAddressLine2>
<dei:EntityAddressCityOrTown contextRef="From2022-01-01to2022-06-30"> Ft. Lauderdale </dei:EntityAddressCityOrTown>
<dei:EntityAddressStateOrProvince contextRef="From2022-01-01to2022-06-30"> FL </dei:EntityAddressStateOrProvince>
<dei:EntityAddressPostalZipCode contextRef="From2022-01-01to2022-06-30"> 33308 </dei:EntityAddressPostalZipCode>
<dei:CityAreaCode contextRef="From2022-01-01to2022-06-30"> 954 </dei:CityAreaCode>
<dei:LocalPhoneNumber contextRef="From2022-01-01to2022-06-30"> 440-4678 </dei:LocalPhoneNumber>
<dei:EntityCurrentReportingStatus contextRef="From2022-01-01to2022-06-30"> Yes </dei:EntityCurrentReportingStatus>
<dei:EntityInteractiveDataCurrent contextRef="From2022-01-01to2022-06-30"> Yes </dei:EntityInteractiveDataCurrent>
<dei:EntityFilerCategory contextRef="From2022-01-01to2022-06-30"> Non-accelerated Filer </dei:EntityFilerCategory>
<dei:EntitySmallBusiness contextRef="From2022-01-01to2022-06-30"> true </dei:EntitySmallBusiness>
<dei:EntityEmergingGrowthCompany contextRef="From2022-01-01to2022-06-30"> false </dei:EntityEmergingGrowthCompany>
<dei:EntityShellCompany contextRef="From2022-01-01to2022-06-30"> false </dei:EntityShellCompany>
<dei:EntityShellCompany contextRef="From2022-01-01to2022-06-30"> false </dei:EntityShellCompany>
<dei:EntityCommonStockSharesOutstanding contextRef="AsOf2022-08-22" decimals="INF" unitRef="Shares"> 117285039 </dei:EntityCommonStockSharesOutstanding>
<us-gaap:Cash contextRef="AsOf2022-06-30" decimals="0" unitRef="USD"> 173845 </us-gaap:Cash>
<us-gaap:Cash contextRef="AsOf2021-12-31" decimals="0" unitRef="USD"> 63418 </us-gaap:Cash>
<us-gaap:PrepaidExpenseCurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD"> 0 </us-gaap:PrepaidExpenseCurrent>
<us-gaap:PrepaidExpenseCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD"> 276043 </us-gaap:PrepaidExpenseCurrent>
<us-gaap:OtherAssetsCurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD"> 17084 </us-gaap:OtherAssetsCurrent>
<us-gaap:OtherAssetsCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD"> 3484 </us-gaap:OtherAssetsCurrent>
<us-gaap:AssetsCurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD"> 190929 </us-gaap:AssetsCurrent>
<us-gaap:AssetsCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD"> 342945 </us-gaap:AssetsCurrent>
<us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2022-06-30" decimals="0" unitRef="USD"> 21376 </us-gaap:PropertyPlantAndEquipmentNet>
<us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2021-12-31" decimals="0" unitRef="USD"> 23376 </us-gaap:PropertyPlantAndEquipmentNet>
<us-gaap:OtherIntangibleAssetsNet contextRef="AsOf2022-06-30" decimals="0" unitRef="USD"> 219142 </us-gaap:OtherIntangibleAssetsNet>
<us-gaap:OtherIntangibleAssetsNet contextRef="AsOf2021-12-31" decimals="0" unitRef="USD"> 0 </us-gaap:OtherIntangibleAssetsNet>
<us-gaap:OperatingLeaseRightOfUseAsset contextRef="AsOf2022-06-30" decimals="0" unitRef="USD"> 278070 </us-gaap:OperatingLeaseRightOfUseAsset>
<us-gaap:OperatingLeaseRightOfUseAsset contextRef="AsOf2021-12-31" decimals="0" unitRef="USD"> 313856 </us-gaap:OperatingLeaseRightOfUseAsset>
<us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="AsOf2022-06-30" decimals="0" unitRef="USD"> 451404 </us-gaap:IntangibleAssetsNetExcludingGoodwill>
<us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="AsOf2021-12-31" decimals="0" unitRef="USD"> 451404 </us-gaap:IntangibleAssetsNetExcludingGoodwill>
<us-gaap:Assets contextRef="AsOf2022-06-30" decimals="0" unitRef="USD"> 1160921 </us-gaap:Assets>
<us-gaap:Assets contextRef="AsOf2021-12-31" decimals="0" unitRef="USD"> 1131581 </us-gaap:Assets>
<us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD"> 646684 </us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
<us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD"> 588870 </us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
<us-gaap:AccountsPayableRelatedPartiesCurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD"> 657237 </us-gaap:AccountsPayableRelatedPartiesCurrent>
<us-gaap:AccountsPayableRelatedPartiesCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD"> 567202 </us-gaap:AccountsPayableRelatedPartiesCurrent>
<us-gaap:OperatingLeaseLiabilityCurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD"> 40455 </us-gaap:OperatingLeaseLiabilityCurrent>
<us-gaap:OperatingLeaseLiabilityCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD"> 69258 </us-gaap:OperatingLeaseLiabilityCurrent>
<us-gaap:LiabilitiesCurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD"> 1344376 </us-gaap:LiabilitiesCurrent>
<us-gaap:LiabilitiesCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD"> 1225330 </us-gaap:LiabilitiesCurrent>
<us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD"> 241521 </us-gaap:OperatingLeaseLiabilityNoncurrent>
<us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD"> 246373 </us-gaap:OperatingLeaseLiabilityNoncurrent>
<mdxl:ConvertibleDebtNetOfDiscount contextRef="AsOf2022-06-30" decimals="0" unitRef="USD"> 77021 </mdxl:ConvertibleDebtNetOfDiscount>
<us-gaap:ConvertibleDebtCurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD"> 1339469 </us-gaap:ConvertibleDebtCurrent>
<us-gaap:Liabilities contextRef="AsOf2022-06-30" decimals="0" unitRef="USD"> 2925366 </us-gaap:Liabilities>
<us-gaap:Liabilities contextRef="AsOf2021-12-31" decimals="0" unitRef="USD"> 1471703 </us-gaap:Liabilities>
<us-gaap:PreferredStockParOrStatedValuePerShare contextRef="AsOf2022-06-30_us-gaap_SeriesAPreferredStockMember" decimals="INF" unitRef="USDPShares"> 0.001 </us-gaap:PreferredStockParOrStatedValuePerShare>
<us-gaap:PreferredStockParOrStatedValuePerShare contextRef="AsOf2021-12-31_us-gaap_SeriesAPreferredStockMember" decimals="INF" unitRef="USDPShares"> 0.001 </us-gaap:PreferredStockParOrStatedValuePerShare>
<us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2022-06-30_us-gaap_SeriesAPreferredStockMember" decimals="INF" unitRef="Shares"> 1000000 </us-gaap:PreferredStockSharesAuthorized>
<us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2021-12-31_us-gaap_SeriesAPreferredStockMember" decimals="INF" unitRef="Shares"> 1000000 </us-gaap:PreferredStockSharesAuthorized>
<us-gaap:PreferredStockSharesIssued contextRef="AsOf2022-06-30_us-gaap_SeriesAPreferredStockMember" decimals="INF" unitRef="Shares"> 264894 </us-gaap:PreferredStockSharesIssued>
<us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2022-06-30_us-gaap_SeriesAPreferredStockMember" decimals="INF" unitRef="Shares"> 264894 </us-gaap:PreferredStockSharesOutstanding>
<us-gaap:PreferredStockSharesIssued contextRef="AsOf2021-12-31_us-gaap_SeriesAPreferredStockMember" decimals="INF" unitRef="Shares"> 264894 </us-gaap:PreferredStockSharesIssued>
<us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2021-12-31_us-gaap_SeriesAPreferredStockMember" decimals="INF" unitRef="Shares"> 264894 </us-gaap:PreferredStockSharesOutstanding>
<us-gaap:PreferredStockValue contextRef="AsOf2022-06-30_us-gaap_SeriesAPreferredStockMember" decimals="0" unitRef="USD"> 265 </us-gaap:PreferredStockValue>
<us-gaap:PreferredStockValue contextRef="AsOf2021-12-31_us-gaap_SeriesAPreferredStockMember" decimals="0" unitRef="USD"> 265 </us-gaap:PreferredStockValue>
<us-gaap:PreferredStockParOrStatedValuePerShare contextRef="AsOf2022-06-30_us-gaap_SeriesBPreferredStockMember" decimals="INF" unitRef="USDPShares"> 0.001 </us-gaap:PreferredStockParOrStatedValuePerShare>
<us-gaap:PreferredStockParOrStatedValuePerShare contextRef="AsOf2021-12-31_us-gaap_SeriesBPreferredStockMember" decimals="INF" unitRef="USDPShares"> 0.001 </us-gaap:PreferredStockParOrStatedValuePerShare>
<us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2022-06-30_us-gaap_SeriesBPreferredStockMember" decimals="INF" unitRef="Shares"> 4000000 </us-gaap:PreferredStockSharesAuthorized>
<us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2021-12-31_us-gaap_SeriesBPreferredStockMember" decimals="INF" unitRef="Shares"> 4000000 </us-gaap:PreferredStockSharesAuthorized>
<us-gaap:PreferredStockSharesIssued contextRef="AsOf2022-06-30_us-gaap_SeriesBPreferredStockMember" decimals="INF" unitRef="Shares"> 3909360 </us-gaap:PreferredStockSharesIssued>
<us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2022-06-30_us-gaap_SeriesBPreferredStockMember" decimals="INF" unitRef="Shares"> 3909360 </us-gaap:PreferredStockSharesOutstanding>
<us-gaap:PreferredStockSharesIssued contextRef="AsOf2021-12-31_us-gaap_SeriesBPreferredStockMember" decimals="INF" unitRef="Shares"> 3909360 </us-gaap:PreferredStockSharesIssued>
<us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2021-12-31_us-gaap_SeriesBPreferredStockMember" decimals="INF" unitRef="Shares"> 3909360 </us-gaap:PreferredStockSharesOutstanding>
<us-gaap:PreferredStockValue contextRef="AsOf2022-06-30_us-gaap_SeriesBPreferredStockMember" decimals="0" unitRef="USD"> 3909 </us-gaap:PreferredStockValue>
<us-gaap:PreferredStockValue contextRef="AsOf2021-12-31_us-gaap_SeriesBPreferredStockMember" decimals="0" unitRef="USD"> 3909 </us-gaap:PreferredStockValue>
<us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2022-06-30" decimals="INF" unitRef="USDPShares"> 0.001 </us-gaap:CommonStockParOrStatedValuePerShare>
<us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2021-12-31" decimals="INF" unitRef="USDPShares"> 0.001 </us-gaap:CommonStockParOrStatedValuePerShare>
<us-gaap:CommonStockSharesAuthorized contextRef="AsOf2022-06-30" decimals="INF" unitRef="Shares"> 750000000 </us-gaap:CommonStockSharesAuthorized>
<us-gaap:CommonStockSharesAuthorized contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares"> 750000000 </us-gaap:CommonStockSharesAuthorized>
<us-gaap:CommonStockSharesIssued contextRef="AsOf2022-06-30" decimals="INF" unitRef="Shares"> 117235039 </us-gaap:CommonStockSharesIssued>
<us-gaap:CommonStockSharesOutstanding contextRef="AsOf2022-06-30" decimals="INF" unitRef="Shares"> 117235039 </us-gaap:CommonStockSharesOutstanding>
<us-gaap:CommonStockSharesIssued contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares"> 110864595 </us-gaap:CommonStockSharesIssued>
<us-gaap:CommonStockSharesOutstanding contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares"> 110864595 </us-gaap:CommonStockSharesOutstanding>
<us-gaap:CommonStockValue contextRef="AsOf2022-06-30" decimals="0" unitRef="USD"> 117235 </us-gaap:CommonStockValue>
<us-gaap:CommonStockValue contextRef="AsOf2021-12-31" decimals="0" unitRef="USD"> 110864 </us-gaap:CommonStockValue>
<us-gaap:AdditionalPaidInCapital contextRef="AsOf2022-06-30" decimals="0" unitRef="USD"> 27860632 </us-gaap:AdditionalPaidInCapital>
<us-gaap:AdditionalPaidInCapital contextRef="AsOf2021-12-31" decimals="0" unitRef="USD"> 25327230 </us-gaap:AdditionalPaidInCapital>
<us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2022-06-30" decimals="0" unitRef="USD"> -29746486 </us-gaap:RetainedEarningsAccumulatedDeficit>
<us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2021-12-31" decimals="0" unitRef="USD"> -25782390 </us-gaap:RetainedEarningsAccumulatedDeficit>
<us-gaap:StockholdersEquity contextRef="AsOf2022-06-30" decimals="0" unitRef="USD"> -1764445 </us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="AsOf2021-12-31" decimals="0" unitRef="USD"> -340122 </us-gaap:StockholdersEquity>
<us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2022-06-30" decimals="0" unitRef="USD"> 1160921 </us-gaap:LiabilitiesAndStockholdersEquity>
<us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2021-12-31" decimals="0" unitRef="USD"> 1131581 </us-gaap:LiabilitiesAndStockholdersEquity>
<us-gaap:Revenues contextRef="From2022-04-012022-06-30" decimals="0" unitRef="USD"> 10352 </us-gaap:Revenues>
<us-gaap:Revenues contextRef="From2021-04-012021-06-30" decimals="0" unitRef="USD"> 166642 </us-gaap:Revenues>
<us-gaap:Revenues contextRef="From2022-01-01to2022-06-30" decimals="0" unitRef="USD"> 18259 </us-gaap:Revenues>
<us-gaap:Revenues contextRef="From2021-01-012021-06-30" decimals="0" unitRef="USD"> 169913 </us-gaap:Revenues>
<us-gaap:ProfessionalFees contextRef="From2022-04-012022-06-30" decimals="0" unitRef="USD"> 267956 </us-gaap:ProfessionalFees>
<us-gaap:ProfessionalFees contextRef="From2021-04-012021-06-30" decimals="0" unitRef="USD"> 342080 </us-gaap:ProfessionalFees>
<us-gaap:ProfessionalFees contextRef="From2022-01-01to2022-06-30" decimals="0" unitRef="USD"> 596613 </us-gaap:ProfessionalFees>
<us-gaap:ProfessionalFees contextRef="From2021-01-012021-06-30" decimals="0" unitRef="USD"> 681660 </us-gaap:ProfessionalFees>
<mdxl:ProfessionalFeesRelatedParty contextRef="From2022-04-012022-06-30" decimals="0" unitRef="USD"> 57500 </mdxl:ProfessionalFeesRelatedParty>
<mdxl:ProfessionalFeesRelatedParty contextRef="From2021-04-012021-06-30" decimals="0" unitRef="USD"> 247000 </mdxl:ProfessionalFeesRelatedParty>
<mdxl:ProfessionalFeesRelatedParty contextRef="From2022-01-01to2022-06-30" decimals="0" unitRef="USD"> 177500 </mdxl:ProfessionalFeesRelatedParty>
<mdxl:ProfessionalFeesRelatedParty contextRef="From2021-01-012021-06-30" decimals="0" unitRef="USD"> 411038 </mdxl:ProfessionalFeesRelatedParty>
<mdxl:ManagementFeeRelatedParty contextRef="From2022-04-012022-06-30" decimals="0" unitRef="USD"> 240000 </mdxl:ManagementFeeRelatedParty>
<mdxl:ManagementFeeRelatedParty contextRef="From2021-04-012021-06-30" decimals="0" unitRef="USD"> 240000 </mdxl:ManagementFeeRelatedParty>
<mdxl:ManagementFeeRelatedParty contextRef="From2022-01-01to2022-06-30" decimals="0" unitRef="USD"> 480000 </mdxl:ManagementFeeRelatedParty>
<mdxl:ManagementFeeRelatedParty contextRef="From2021-01-012021-06-30" decimals="0" unitRef="USD"> 360000 </mdxl:ManagementFeeRelatedParty>
<us-gaap:LaborAndRelatedExpense contextRef="From2022-04-012022-06-30" decimals="0" unitRef="USD"> 783961 </us-gaap:LaborAndRelatedExpense>
<us-gaap:LaborAndRelatedExpense contextRef="From2021-04-012021-06-30" decimals="0" unitRef="USD"> 682361 </us-gaap:LaborAndRelatedExpense>
<us-gaap:LaborAndRelatedExpense contextRef="From2022-01-01to2022-06-30" decimals="0" unitRef="USD"> 2313915 </us-gaap:LaborAndRelatedExpense>
<us-gaap:LaborAndRelatedExpense contextRef="From2021-01-012021-06-30" decimals="0" unitRef="USD"> 1283911 </us-gaap:LaborAndRelatedExpense>
<us-gaap:OtherSellingGeneralAndAdministrativeExpense contextRef="From2022-04-012022-06-30" decimals="0" unitRef="USD"> 214929 </us-gaap:OtherSellingGeneralAndAdministrativeExpense>
<us-gaap:OtherSellingGeneralAndAdministrativeExpense contextRef="From2021-04-012021-06-30" decimals="0" unitRef="USD"> 314417 </us-gaap:OtherSellingGeneralAndAdministrativeExpense>
<us-gaap:OtherSellingGeneralAndAdministrativeExpense contextRef="From2022-01-01to2022-06-30" decimals="0" unitRef="USD"> 414327 </us-gaap:OtherSellingGeneralAndAdministrativeExpense>
<us-gaap:OtherSellingGeneralAndAdministrativeExpense contextRef="From2021-01-012021-06-30" decimals="0" unitRef="USD"> 424821 </us-gaap:OtherSellingGeneralAndAdministrativeExpense>
<us-gaap:OperatingExpenses contextRef="From2022-04-012022-06-30" decimals="0" unitRef="USD"> 1564346 </us-gaap:OperatingExpenses>
<us-gaap:OperatingExpenses contextRef="From2021-04-012021-06-30" decimals="0" unitRef="USD"> 1825858 </us-gaap:OperatingExpenses>
<us-gaap:OperatingExpenses contextRef="From2022-01-01to2022-06-30" decimals="0" unitRef="USD"> 3982355 </us-gaap:OperatingExpenses>
<us-gaap:OperatingExpenses contextRef="From2021-01-012021-06-30" decimals="0" unitRef="USD"> 3161430 </us-gaap:OperatingExpenses>
<us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="From2022-04-012022-06-30" decimals="0" unitRef="USD"> -1553994 </us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
<us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="From2021-04-012021-06-30" decimals="0" unitRef="USD"> -1659216 </us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
<us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="From2022-01-01to2022-06-30" decimals="0" unitRef="USD"> -3964096 </us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
<us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="From2021-01-012021-06-30" decimals="0" unitRef="USD"> -2991517 </us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
<us-gaap:IncomeTaxExpenseBenefit contextRef="From2022-04-012022-06-30" decimals="0" unitRef="USD"> 0 </us-gaap:IncomeTaxExpenseBenefit>
<us-gaap:IncomeTaxExpenseBenefit contextRef="From2021-04-012021-06-30" decimals="0" unitRef="USD"> 0 </us-gaap:IncomeTaxExpenseBenefit>
<us-gaap:IncomeTaxExpenseBenefit contextRef="From2022-01-01to2022-06-30" decimals="0" unitRef="USD"> 0 </us-gaap:IncomeTaxExpenseBenefit>
<us-gaap:IncomeTaxExpenseBenefit contextRef="From2021-01-012021-06-30" decimals="0" unitRef="USD"> 0 </us-gaap:IncomeTaxExpenseBenefit>
<us-gaap:NetIncomeLoss contextRef="From2022-04-012022-06-30" decimals="0" unitRef="USD"> -1553994 </us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="From2021-04-012021-06-30" decimals="0" unitRef="USD"> -1659216 </us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="From2022-01-01to2022-06-30" decimals="0" unitRef="USD"> -3964096 </us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="From2021-01-012021-06-30" decimals="0" unitRef="USD"> -2991517 </us-gaap:NetIncomeLoss>
<us-gaap:DividendsPreferredStock contextRef="From2022-04-012022-06-30" decimals="0" unitRef="USD"> 73649 </us-gaap:DividendsPreferredStock>
<us-gaap:DividendsPreferredStock contextRef="From2021-04-012021-06-30" decimals="0" unitRef="USD"> 59687 </us-gaap:DividendsPreferredStock>
<us-gaap:DividendsPreferredStock contextRef="From2022-01-01to2022-06-30" decimals="0" unitRef="USD"> 146488 </us-gaap:DividendsPreferredStock>
<us-gaap:DividendsPreferredStock contextRef="From2021-01-012021-06-30" decimals="0" unitRef="USD"> 106656 </us-gaap:DividendsPreferredStock>
<us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="From2022-04-012022-06-30" decimals="0" unitRef="USD"> -1627643 </us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
<us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="From2021-04-012021-06-30" decimals="0" unitRef="USD"> -1718903 </us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
<us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="From2022-01-01to2022-06-30" decimals="0" unitRef="USD"> -4110584 </us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
<us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="From2021-01-012021-06-30" decimals="0" unitRef="USD"> -3098173 </us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
<us-gaap:EarningsPerShareBasic contextRef="From2022-04-012022-06-30" decimals="INF" unitRef="USDPShares"> -0.01 </us-gaap:EarningsPerShareBasic>
<us-gaap:EarningsPerShareBasic contextRef="From2021-04-012021-06-30" decimals="INF" unitRef="USDPShares"> -0.02 </us-gaap:EarningsPerShareBasic>
<us-gaap:EarningsPerShareBasic contextRef="From2022-01-01to2022-06-30" decimals="INF" unitRef="USDPShares"> -0.04 </us-gaap:EarningsPerShareBasic>
<us-gaap:EarningsPerShareBasic contextRef="From2021-01-012021-06-30" decimals="INF" unitRef="USDPShares"> -0.03 </us-gaap:EarningsPerShareBasic>
<us-gaap:EarningsPerShareDiluted contextRef="From2022-04-012022-06-30" decimals="INF" unitRef="USDPShares"> -0.01 </us-gaap:EarningsPerShareDiluted>
<us-gaap:EarningsPerShareDiluted contextRef="From2021-04-012021-06-30" decimals="INF" unitRef="USDPShares"> -0.02 </us-gaap:EarningsPerShareDiluted>
<us-gaap:EarningsPerShareDiluted contextRef="From2022-01-01to2022-06-30" decimals="INF" unitRef="USDPShares"> -0.04 </us-gaap:EarningsPerShareDiluted>
<us-gaap:EarningsPerShareDiluted contextRef="From2021-01-012021-06-30" decimals="INF" unitRef="USDPShares"> -0.03 </us-gaap:EarningsPerShareDiluted>
<us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="From2022-04-012022-06-30" decimals="INF" unitRef="Shares"> 116151261 </us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
<us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="From2021-04-012021-06-30" decimals="INF" unitRef="Shares"> 102075557 </us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
<us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="From2022-01-01to2022-06-30" decimals="INF" unitRef="Shares"> 115392749 </us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
<us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="From2021-01-012021-06-30" decimals="INF" unitRef="Shares"> 101177844 </us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
<us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="From2022-04-012022-06-30" decimals="INF" unitRef="Shares"> 116151261 </us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
<us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="From2021-04-012021-06-30" decimals="INF" unitRef="Shares"> 102075557 </us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
<us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="From2022-01-01to2022-06-30" decimals="INF" unitRef="Shares"> 115392749 </us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
<us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="From2021-01-012021-06-30" decimals="INF" unitRef="Shares"> 101177844 </us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
<us-gaap:SharesOutstanding contextRef="AsOf2020-12-31_custom_SeriesAVotingPreferredStockMember" decimals="INF" unitRef="Shares"> 264894 </us-gaap:SharesOutstanding>
<us-gaap:StockholdersEquity contextRef="AsOf2020-12-31_custom_SeriesAVotingPreferredStockMember" decimals="0" unitRef="USD"> 265 </us-gaap:StockholdersEquity>
<us-gaap:SharesOutstanding contextRef="AsOf2020-12-31_custom_SeriesBVotingPreferredStockMember" decimals="INF" unitRef="Shares"> 1639360 </us-gaap:SharesOutstanding>
<us-gaap:StockholdersEquity contextRef="AsOf2020-12-31_custom_SeriesBVotingPreferredStockMember" decimals="0" unitRef="USD"> 1639 </us-gaap:StockholdersEquity>
<us-gaap:SharesOutstanding contextRef="AsOf2020-12-31_us-gaap_CommonStockMember" decimals="INF" unitRef="Shares"> 98898130 </us-gaap:SharesOutstanding>
<us-gaap:StockholdersEquity contextRef="AsOf2020-12-31_us-gaap_CommonStockMember" decimals="0" unitRef="USD"> 98898 </us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember" decimals="0" unitRef="USD"> 19862918 </us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="AsOf2020-12-31_us-gaap_RetainedEarningsMember" decimals="0" unitRef="USD"> -19581816 </us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="AsOf2020-12-31" decimals="0" unitRef="USD"> 381904 </us-gaap:StockholdersEquity>
<us-gaap:PaymentsOfStockIssuanceCosts contextRef="From2021-01-012021-03-31_us-gaap_CommonStockMember" decimals="0" unitRef="USD"> 0 </us-gaap:PaymentsOfStockIssuanceCosts>
<us-gaap:StockIssuedDuringPeriodSharesOther contextRef="From2021-01-012021-03-31_us-gaap_CommonStockMember" decimals="INF" unitRef="Shares"> 2487550 </us-gaap:StockIssuedDuringPeriodSharesOther>
<us-gaap:StockIssuedDuringPeriodValueOther contextRef="From2021-01-012021-03-31_us-gaap_CommonStockMember" decimals="0" unitRef="USD"> 2488 </us-gaap:StockIssuedDuringPeriodValueOther>
<us-gaap:StockIssuedDuringPeriodValueOther contextRef="From2021-01-012021-03-31_us-gaap_AdditionalPaidInCapitalMember" decimals="0" unitRef="USD"> 619387 </us-gaap:StockIssuedDuringPeriodValueOther>
<us-gaap:StockIssuedDuringPeriodValueOther contextRef="From2021-01-012021-03-31" decimals="0" unitRef="USD"> 621875 </us-gaap:StockIssuedDuringPeriodValueOther>
<mdxl:ProceedsReceivedFromSaleOfPreferredStockShares contextRef="From2021-01-012021-03-31_custom_SeriesBVotingPreferredStockMember" decimals="INF" unitRef="Shares"> 1345000 </mdxl:ProceedsReceivedFromSaleOfPreferredStockShares>
<mdxl:ProceedsReceivedFromSaleOfPreferredStock contextRef="From2021-01-012021-03-31_custom_SeriesBVotingPreferredStockMember" decimals="0" unitRef="USD"> 1345 </mdxl:ProceedsReceivedFromSaleOfPreferredStock>
<mdxl:ProceedsReceivedFromSaleOfPreferredStock contextRef="From2021-01-012021-03-31_us-gaap_AdditionalPaidInCapitalMember" decimals="0" unitRef="USD"> 1343655 </mdxl:ProceedsReceivedFromSaleOfPreferredStock>
<mdxl:ProceedsReceivedFromSaleOfPreferredStock contextRef="From2021-01-012021-03-31" decimals="0" unitRef="USD"> 1345000 </mdxl:ProceedsReceivedFromSaleOfPreferredStock>
<us-gaap:NetIncomeLoss contextRef="From2021-01-012021-03-31_us-gaap_RetainedEarningsMember" decimals="0" unitRef="USD"> -1332301 </us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="From2021-01-012021-03-31" decimals="0" unitRef="USD"> -1332301 </us-gaap:NetIncomeLoss>
<us-gaap:SharesOutstanding contextRef="AsOf2021-03-31_custom_SeriesAVotingPreferredStockMember" decimals="INF" unitRef="Shares"> 264894 </us-gaap:SharesOutstanding>
<us-gaap:StockholdersEquity contextRef="AsOf2021-03-31_custom_SeriesAVotingPreferredStockMember" decimals="0" unitRef="USD"> 265 </us-gaap:StockholdersEquity>
<us-gaap:SharesOutstanding contextRef="AsOf2021-03-31_custom_SeriesBVotingPreferredStockMember" decimals="INF" unitRef="Shares"> 2984360 </us-gaap:SharesOutstanding>
<us-gaap:StockholdersEquity contextRef="AsOf2021-03-31_custom_SeriesBVotingPreferredStockMember" decimals="0" unitRef="USD"> 2984 </us-gaap:StockholdersEquity>
<us-gaap:SharesOutstanding contextRef="AsOf2021-03-31_us-gaap_CommonStockMember" decimals="INF" unitRef="Shares"> 101385680 </us-gaap:SharesOutstanding>
<us-gaap:StockholdersEquity contextRef="AsOf2021-03-31_us-gaap_CommonStockMember" decimals="0" unitRef="USD"> 101386 </us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="AsOf2021-03-31_us-gaap_AdditionalPaidInCapitalMember" decimals="0" unitRef="USD"> 21825960 </us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="AsOf2021-03-31_us-gaap_RetainedEarningsMember" decimals="0" unitRef="USD"> -20914117 </us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="AsOf2021-03-31" decimals="0" unitRef="USD"> 1016478 </us-gaap:StockholdersEquity>
<us-gaap:PaymentsOfStockIssuanceCosts contextRef="From2021-04-012021-06-30_us-gaap_CommonStockMember" decimals="0" unitRef="USD"> 0 </us-gaap:PaymentsOfStockIssuanceCosts>
<us-gaap:StockIssuedDuringPeriodSharesOther contextRef="From2021-04-012021-06-30_us-gaap_CommonStockMember" decimals="INF" unitRef="Shares"> 1290000 </us-gaap:StockIssuedDuringPeriodSharesOther>
<us-gaap:StockIssuedDuringPeriodValueOther contextRef="From2021-04-012021-06-30_us-gaap_CommonStockMember" decimals="0" unitRef="USD"> 1289 </us-gaap:StockIssuedDuringPeriodValueOther>
<us-gaap:StockIssuedDuringPeriodValueOther contextRef="From2021-04-012021-06-30_us-gaap_AdditionalPaidInCapitalMember" decimals="0" unitRef="USD"> 326211 </us-gaap:StockIssuedDuringPeriodValueOther>
<us-gaap:StockIssuedDuringPeriodValueOther contextRef="From2021-04-012021-06-30" decimals="0" unitRef="USD"> 327500 </us-gaap:StockIssuedDuringPeriodValueOther>
<us-gaap:StockIssuedDuringPeriodSharesIssuedForServices contextRef="From2021-04-012021-06-30_us-gaap_CommonStockMember" decimals="INF" unitRef="Shares"> 2713500 </us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
<us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="From2021-04-012021-06-30_us-gaap_CommonStockMember" decimals="0" unitRef="USD"> 2714 </us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
<us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="From2021-04-012021-06-30_us-gaap_AdditionalPaidInCapitalMember" decimals="0" unitRef="USD"> 675661 </us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
<us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="From2021-04-012021-06-30" decimals="0" unitRef="USD"> 678375 </us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
<us-gaap:NetIncomeLoss contextRef="From2021-04-012021-06-30_us-gaap_RetainedEarningsMember" decimals="0" unitRef="USD"> -1659216 </us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="From2021-04-012021-06-30" decimals="0" unitRef="USD"> -1659216 </us-gaap:NetIncomeLoss>
<us-gaap:SharesOutstanding contextRef="AsOf2021-06-30_custom_SeriesAVotingPreferredStockMember" decimals="INF" unitRef="Shares"> 264894 </us-gaap:SharesOutstanding>
<us-gaap:StockholdersEquity contextRef="AsOf2021-06-30_custom_SeriesAVotingPreferredStockMember" decimals="0" unitRef="USD"> 265 </us-gaap:StockholdersEquity>
<us-gaap:SharesOutstanding contextRef="AsOf2021-06-30_custom_SeriesBVotingPreferredStockMember" decimals="INF" unitRef="Shares"> 2984360 </us-gaap:SharesOutstanding>
<us-gaap:StockholdersEquity contextRef="AsOf2021-06-30_custom_SeriesBVotingPreferredStockMember" decimals="0" unitRef="USD"> 2984 </us-gaap:StockholdersEquity>
<us-gaap:SharesOutstanding contextRef="AsOf2021-06-30_us-gaap_CommonStockMember" decimals="INF" unitRef="Shares"> 105389180 </us-gaap:SharesOutstanding>
<us-gaap:StockholdersEquity contextRef="AsOf2021-06-30_us-gaap_CommonStockMember" decimals="0" unitRef="USD"> 105389 </us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="AsOf2021-06-30_us-gaap_AdditionalPaidInCapitalMember" decimals="0" unitRef="USD"> 22827832 </us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="AsOf2021-06-30_us-gaap_RetainedEarningsMember" decimals="0" unitRef="USD"> -22573333 </us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="AsOf2021-06-30" decimals="0" unitRef="USD"> 363137 </us-gaap:StockholdersEquity>
<us-gaap:SharesOutstanding contextRef="AsOf2021-12-31_custom_SeriesAVotingPreferredStockMember" decimals="INF" unitRef="Shares"> 264894 </us-gaap:SharesOutstanding>
<us-gaap:StockholdersEquity contextRef="AsOf2021-12-31_custom_SeriesAVotingPreferredStockMember" decimals="0" unitRef="USD"> 265 </us-gaap:StockholdersEquity>
<us-gaap:SharesOutstanding contextRef="AsOf2021-12-31_custom_SeriesBVotingPreferredStockMember" decimals="INF" unitRef="Shares"> 3909360 </us-gaap:SharesOutstanding>
<us-gaap:StockholdersEquity contextRef="AsOf2021-12-31_custom_SeriesBVotingPreferredStockMember" decimals="0" unitRef="USD"> 3909 </us-gaap:StockholdersEquity>
<us-gaap:SharesOutstanding contextRef="AsOf2021-12-31_us-gaap_CommonStockMember" decimals="INF" unitRef="Shares"> 110864595 </us-gaap:SharesOutstanding>
<us-gaap:StockholdersEquity contextRef="AsOf2021-12-31_us-gaap_CommonStockMember" decimals="0" unitRef="USD"> 110864 </us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember" decimals="0" unitRef="USD"> 25327230 </us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="AsOf2021-12-31_us-gaap_RetainedEarningsMember" decimals="0" unitRef="USD"> -25782390 </us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="AsOf2021-12-31" decimals="0" unitRef="USD"> -340122 </us-gaap:StockholdersEquity>
<us-gaap:PaymentsOfStockIssuanceCosts contextRef="From2022-01-012022-03-31_us-gaap_CommonStockMember" decimals="0" unitRef="USD"> 0 </us-gaap:PaymentsOfStockIssuanceCosts>
<us-gaap:StockIssuedDuringPeriodSharesOther contextRef="From2022-01-012022-03-31_us-gaap_CommonStockMember" decimals="INF" unitRef="Shares"> 1800000 </us-gaap:StockIssuedDuringPeriodSharesOther>
<us-gaap:StockIssuedDuringPeriodValueOther contextRef="From2022-01-012022-03-31_us-gaap_CommonStockMember" decimals="0" unitRef="USD"> 1800 </us-gaap:StockIssuedDuringPeriodValueOther>
<us-gaap:StockIssuedDuringPeriodValueOther contextRef="From2022-01-012022-03-31_us-gaap_AdditionalPaidInCapitalMember" decimals="0" unitRef="USD"> 718200 </us-gaap:StockIssuedDuringPeriodValueOther>
<us-gaap:StockIssuedDuringPeriodValueOther contextRef="From2022-01-012022-03-31" decimals="0" unitRef="USD"> 720000 </us-gaap:StockIssuedDuringPeriodValueOther>
<us-gaap:StockIssuedDuringPeriodSharesIssuedForServices contextRef="From2022-01-012022-03-31_us-gaap_CommonStockMember" decimals="INF" unitRef="Shares"> 2737325 </us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
<us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="From2022-01-012022-03-31_us-gaap_CommonStockMember" decimals="0" unitRef="USD"> 2737 </us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
<us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="From2022-01-012022-03-31_us-gaap_AdditionalPaidInCapitalMember" decimals="0" unitRef="USD"> 1092192 </us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
<us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="From2022-01-012022-03-31" decimals="0" unitRef="USD"> 1094929 </us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
<mdxl:CommonStockIssuedInExchangeForRighttouseIntellectualPropertyShares contextRef="From2022-01-012022-03-31_us-gaap_CommonStockMember" decimals="INF" unitRef="Shares"> 500000 </mdxl:CommonStockIssuedInExchangeForRighttouseIntellectualPropertyShares>
<mdxl:CommonStockIssuedInExchangeForRighttouseIntellectualProperty contextRef="From2022-01-012022-03-31_us-gaap_CommonStockMember" decimals="0" unitRef="USD"> 500 </mdxl:CommonStockIssuedInExchangeForRighttouseIntellectualProperty>
<mdxl:CommonStockIssuedInExchangeForRighttouseIntellectualProperty contextRef="From2022-01-012022-03-31_us-gaap_AdditionalPaidInCapitalMember" decimals="0" unitRef="USD"> 235500 </mdxl:CommonStockIssuedInExchangeForRighttouseIntellectualProperty>
<mdxl:CommonStockIssuedInExchangeForRighttouseIntellectualProperty contextRef="From2022-01-012022-03-31" decimals="0" unitRef="USD"> 236000 </mdxl:CommonStockIssuedInExchangeForRighttouseIntellectualProperty>
<mdxl:FairValueOfWarrantsIssuedWithConvertibleDebentures contextRef="From2022-01-012022-03-31_us-gaap_AdditionalPaidInCapitalMember" decimals="0" unitRef="USD"> 23800 </mdxl:FairValueOfWarrantsIssuedWithConvertibleDebentures>
<mdxl:FairValueOfWarrantsIssuedWithConvertibleDebentures contextRef="From2022-01-012022-03-31" decimals="0" unitRef="USD"> 23800 </mdxl:FairValueOfWarrantsIssuedWithConvertibleDebentures>
<us-gaap:NetIncomeLoss contextRef="From2022-01-012022-03-31_us-gaap_RetainedEarningsMember" decimals="0" unitRef="USD"> -2410102 </us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="From2022-01-012022-03-31" decimals="0" unitRef="USD"> -2410102 </us-gaap:NetIncomeLoss>
<us-gaap:SharesOutstanding contextRef="AsOf2022-03-31_custom_SeriesAVotingPreferredStockMember" decimals="INF" unitRef="Shares"> 264894 </us-gaap:SharesOutstanding>
<us-gaap:StockholdersEquity contextRef="AsOf2022-03-31_custom_SeriesAVotingPreferredStockMember" decimals="0" unitRef="USD"> 265 </us-gaap:StockholdersEquity>
<us-gaap:SharesOutstanding contextRef="AsOf2022-03-31_custom_SeriesBVotingPreferredStockMember" decimals="INF" unitRef="Shares"> 3909360 </us-gaap:SharesOutstanding>
<us-gaap:StockholdersEquity contextRef="AsOf2022-03-31_custom_SeriesBVotingPreferredStockMember" decimals="0" unitRef="USD"> 3909 </us-gaap:StockholdersEquity>
<us-gaap:SharesOutstanding contextRef="AsOf2022-03-31_us-gaap_CommonStockMember" decimals="INF" unitRef="Shares"> 115901920 </us-gaap:SharesOutstanding>
<us-gaap:StockholdersEquity contextRef="AsOf2022-03-31_us-gaap_CommonStockMember" decimals="0" unitRef="USD"> 115901 </us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="AsOf2022-03-31_us-gaap_AdditionalPaidInCapitalMember" decimals="0" unitRef="USD"> 27396922 </us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="AsOf2022-03-31_us-gaap_RetainedEarningsMember" decimals="0" unitRef="USD"> -28192492 </us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="AsOf2022-03-31" decimals="0" unitRef="USD"> -675495 </us-gaap:StockholdersEquity>
<us-gaap:PaymentsOfStockIssuanceCosts contextRef="From2022-04-012022-06-30_us-gaap_CommonStockMember" decimals="0" unitRef="USD"> 0 </us-gaap:PaymentsOfStockIssuanceCosts>
<us-gaap:StockIssuedDuringPeriodSharesOther contextRef="From2022-04-012022-06-30_us-gaap_CommonStockMember" decimals="INF" unitRef="Shares"> 101250 </us-gaap:StockIssuedDuringPeriodSharesOther>
<us-gaap:StockIssuedDuringPeriodValueOther contextRef="From2022-04-012022-06-30_us-gaap_CommonStockMember" decimals="0" unitRef="USD"> 102 </us-gaap:StockIssuedDuringPeriodValueOther>
<us-gaap:StockIssuedDuringPeriodValueOther contextRef="From2022-04-012022-06-30_us-gaap_AdditionalPaidInCapitalMember" decimals="0" unitRef="USD"> 40398 </us-gaap:StockIssuedDuringPeriodValueOther>
<us-gaap:StockIssuedDuringPeriodValueOther contextRef="From2022-04-012022-06-30" decimals="0" unitRef="USD"> 40500 </us-gaap:StockIssuedDuringPeriodValueOther>
<us-gaap:StockIssuedDuringPeriodSharesIssuedForServices contextRef="From2022-04-012022-06-30_us-gaap_CommonStockMember" decimals="INF" unitRef="Shares"> 1231869 </us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
<us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="From2022-04-012022-06-30_us-gaap_CommonStockMember" decimals="0" unitRef="USD"> 1232 </us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
<us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="From2022-04-012022-06-30_us-gaap_AdditionalPaidInCapitalMember" decimals="0" unitRef="USD"> 364166 </us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
<us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="From2022-04-012022-06-30" decimals="0" unitRef="USD"> 365398 </us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
<mdxl:FairValueOfWarrantsIssuedWithConvertibleDebentures contextRef="From2022-04-012022-06-30_us-gaap_AdditionalPaidInCapitalMember" decimals="0" unitRef="USD"> 59146 </mdxl:FairValueOfWarrantsIssuedWithConvertibleDebentures>
<mdxl:FairValueOfWarrantsIssuedWithConvertibleDebentures contextRef="From2022-04-012022-06-30" decimals="0" unitRef="USD"> 59146 </mdxl:FairValueOfWarrantsIssuedWithConvertibleDebentures>
<us-gaap:NetIncomeLoss contextRef="From2022-04-012022-06-30_us-gaap_RetainedEarningsMember" decimals="0" unitRef="USD"> -1553994 </us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="From2022-04-012022-06-30" decimals="0" unitRef="USD"> -1553994 </us-gaap:NetIncomeLoss>
<us-gaap:SharesOutstanding contextRef="AsOf2022-06-30_custom_SeriesAVotingPreferredStockMember" decimals="INF" unitRef="Shares"> 264894 </us-gaap:SharesOutstanding>
<us-gaap:StockholdersEquity contextRef="AsOf2022-06-30_custom_SeriesAVotingPreferredStockMember" decimals="0" unitRef="USD"> 265 </us-gaap:StockholdersEquity>
<us-gaap:SharesOutstanding contextRef="AsOf2022-06-30_custom_SeriesBVotingPreferredStockMember" decimals="INF" unitRef="Shares"> 3909360 </us-gaap:SharesOutstanding>
<us-gaap:StockholdersEquity contextRef="AsOf2022-06-30_custom_SeriesBVotingPreferredStockMember" decimals="0" unitRef="USD"> 3909 </us-gaap:StockholdersEquity>
<us-gaap:SharesOutstanding contextRef="AsOf2022-06-30_us-gaap_CommonStockMember" decimals="INF" unitRef="Shares"> 117235039 </us-gaap:SharesOutstanding>
<us-gaap:StockholdersEquity contextRef="AsOf2022-06-30_us-gaap_CommonStockMember" decimals="0" unitRef="USD"> 117235 </us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="AsOf2022-06-30_us-gaap_AdditionalPaidInCapitalMember" decimals="0" unitRef="USD"> 27860632 </us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="AsOf2022-06-30_us-gaap_RetainedEarningsMember" decimals="0" unitRef="USD"> -29746486 </us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="AsOf2022-06-30" decimals="0" unitRef="USD"> -1764445 </us-gaap:StockholdersEquity>
<us-gaap:NetIncomeLoss contextRef="From2022-01-01to2022-06-30" decimals="0" unitRef="USD"> -3964096 </us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="From2021-01-012021-06-30" decimals="0" unitRef="USD"> -2991517 </us-gaap:NetIncomeLoss>
<us-gaap:Depreciation contextRef="From2022-01-01to2022-06-30" decimals="0" unitRef="USD"> 3680 </us-gaap:Depreciation>
<us-gaap:Depreciation contextRef="From2021-01-012021-06-30" decimals="0" unitRef="USD"> 2840 </us-gaap:Depreciation>
<us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims contextRef="From2022-01-01to2022-06-30" decimals="0" unitRef="USD"> 1460327 </us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
<us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims contextRef="From2021-01-012021-06-30" decimals="0" unitRef="USD"> 678375 </us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
<mdxl:AmortizationOfDebentureDiscounts contextRef="From2022-01-01to2022-06-30" decimals="0" unitRef="USD"> -5925 </mdxl:AmortizationOfDebentureDiscounts>
<mdxl:AmortizationOfDebentureDiscounts contextRef="From2021-01-012021-06-30" decimals="0" unitRef="USD"> -0 </mdxl:AmortizationOfDebentureDiscounts>
<mdxl:GainFromForgivenessOfNotePayable contextRef="From2022-01-01to2022-06-30" decimals="0" unitRef="USD"> -0 </mdxl:GainFromForgivenessOfNotePayable>
<mdxl:GainFromForgivenessOfNotePayable contextRef="From2021-01-012021-06-30" decimals="0" unitRef="USD"> 165719 </mdxl:GainFromForgivenessOfNotePayable>
<us-gaap:IncreaseDecreaseInOtherCurrentAssets contextRef="From2022-01-01to2022-06-30" decimals="0" unitRef="USD"> 13600 </us-gaap:IncreaseDecreaseInOtherCurrentAssets>
<us-gaap:IncreaseDecreaseInOtherCurrentAssets contextRef="From2021-01-012021-06-30" decimals="0" unitRef="USD"> -8000 </us-gaap:IncreaseDecreaseInOtherCurrentAssets>
<mdxl:IncreaseDecreaseInPrepaidExpensesRelatedParty contextRef="From2022-01-01to2022-06-30" decimals="0" unitRef="USD"> 276043 </mdxl:IncreaseDecreaseInPrepaidExpensesRelatedParty>
<mdxl:IncreaseDecreaseInPrepaidExpensesRelatedParty contextRef="From2021-01-012021-06-30" decimals="0" unitRef="USD"> 15000 </mdxl:IncreaseDecreaseInPrepaidExpensesRelatedParty>
<us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="From2022-01-01to2022-06-30" decimals="0" unitRef="USD"> 57814 </us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
<us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="From2021-01-012021-06-30" decimals="0" unitRef="USD"> -346969 </us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
<us-gaap:IncreaseDecreaseInAccountsPayableRelatedParties contextRef="From2022-01-01to2022-06-30" decimals="0" unitRef="USD"> 90035 </us-gaap:IncreaseDecreaseInAccountsPayableRelatedParties>
<us-gaap:IncreaseDecreaseInAccountsPayableRelatedParties contextRef="From2021-01-012021-06-30" decimals="0" unitRef="USD"> 0 </us-gaap:IncreaseDecreaseInAccountsPayableRelatedParties>
<mdxl:AmortizationOfRightofuseOperatingLeaseAsset contextRef="From2022-01-01to2022-06-30" decimals="0" unitRef="USD"> 35786 </mdxl:AmortizationOfRightofuseOperatingLeaseAsset>
<mdxl:AmortizationOfRightofuseOperatingLeaseAsset contextRef="From2021-01-012021-06-30" decimals="0" unitRef="USD"> 36754 </mdxl:AmortizationOfRightofuseOperatingLeaseAsset>
<mdxl:AmortizationOfRighttouseIntellectualProperty contextRef="From2022-01-01to2022-06-30" decimals="0" unitRef="USD"> 16858 </mdxl:AmortizationOfRighttouseIntellectualProperty>
<mdxl:AmortizationOfRighttouseIntellectualProperty contextRef="From2021-01-012021-06-30" decimals="0" unitRef="USD"> 0 </mdxl:AmortizationOfRighttouseIntellectualProperty>
<us-gaap:IncreaseDecreaseInOperatingLiabilities contextRef="From2022-01-01to2022-06-30" decimals="0" unitRef="USD"> -33655 </us-gaap:IncreaseDecreaseInOperatingLiabilities>
<us-gaap:IncreaseDecreaseInOperatingLiabilities contextRef="From2021-01-012021-06-30" decimals="0" unitRef="USD"> -38707 </us-gaap:IncreaseDecreaseInOperatingLiabilities>
<us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="From2022-01-01to2022-06-30" decimals="0" unitRef="USD"> -2064883 </us-gaap:NetCashProvidedByUsedInOperatingActivities>
<us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="From2021-01-012021-06-30" decimals="0" unitRef="USD"> -2801943 </us-gaap:NetCashProvidedByUsedInOperatingActivities>
<mdxl:WebsiteAndDevelopmentCosts contextRef="From2022-01-01to2022-06-30" decimals="0" unitRef="USD"> 1680 </mdxl:WebsiteAndDevelopmentCosts>
<mdxl:WebsiteAndDevelopmentCosts contextRef="From2021-01-012021-06-30" decimals="0" unitRef="USD"> 12840 </mdxl:WebsiteAndDevelopmentCosts>
<us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="From2022-01-01to2022-06-30" decimals="0" unitRef="USD"> -1680 </us-gaap:NetCashProvidedByUsedInInvestingActivities>
<us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="From2021-01-012021-06-30" decimals="0" unitRef="USD"> -12840 </us-gaap:NetCashProvidedByUsedInInvestingActivities>
<us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="From2022-01-01to2022-06-30" decimals="0" unitRef="USD"> 760500 </us-gaap:ProceedsFromIssuanceOfCommonStock>
<us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="From2021-01-012021-06-30" decimals="0" unitRef="USD"> 949375 </us-gaap:ProceedsFromIssuanceOfCommonStock>
<us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock contextRef="From2022-01-01to2022-06-30" decimals="0" unitRef="USD"> 0 </us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
<us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock contextRef="From2021-01-012021-06-30" decimals="0" unitRef="USD"> 1345000 </us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
<us-gaap:ProceedsFromConvertibleDebt contextRef="From2022-01-01to2022-06-30" decimals="0" unitRef="USD"> 1416490 </us-gaap:ProceedsFromConvertibleDebt>
<us-gaap:ProceedsFromConvertibleDebt contextRef="From2021-01-012021-06-30" decimals="0" unitRef="USD"> 0 </us-gaap:ProceedsFromConvertibleDebt>
<us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="From2022-01-01to2022-06-30" decimals="0" unitRef="USD"> 2176990 </us-gaap:NetCashProvidedByUsedInFinancingActivities>
<us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="From2021-01-012021-06-30" decimals="0" unitRef="USD"> 2294375 </us-gaap:NetCashProvidedByUsedInFinancingActivities>
<us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect contextRef="From2022-01-01to2022-06-30" decimals="0" unitRef="USD"> 110427 </us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
<us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect contextRef="From2021-01-012021-06-30" decimals="0" unitRef="USD"> -520408 </us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
<us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="AsOf2021-12-31" decimals="0" unitRef="USD"> 63418 </us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
<us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="AsOf2020-12-31" decimals="0" unitRef="USD"> 645762 </us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
<us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="AsOf2022-06-30" decimals="0" unitRef="USD"> 173845 </us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
<us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="AsOf2021-06-30" decimals="0" unitRef="USD"> 125354 </us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
<mdxl:IssuanceOfCommonStockInExchangeForRighttouseIntellectualProperty contextRef="From2022-01-01to2022-06-30" decimals="0" unitRef="USD"> 236000 </mdxl:IssuanceOfCommonStockInExchangeForRighttouseIntellectualProperty>
<mdxl:IssuanceOfCommonStockInExchangeForRighttouseIntellectualProperty contextRef="From2021-01-012021-06-30" decimals="0" unitRef="USD"> 0 </mdxl:IssuanceOfCommonStockInExchangeForRighttouseIntellectualProperty>
<mdxl:DiscountIssuedWithConvertibleDebentures contextRef="From2022-01-01to2022-06-30" decimals="0" unitRef="USD"> 82946 </mdxl:DiscountIssuedWithConvertibleDebentures>
<mdxl:DiscountIssuedWithConvertibleDebentures contextRef="From2021-01-012021-06-30" decimals="0" unitRef="USD"> 0 </mdxl:DiscountIssuedWithConvertibleDebentures>
<mdxl:DecreaseInNotePayableResultingFromGainOnForgivenessOfNotePayable contextRef="From2022-01-01to2022-06-30" decimals="0" unitRef="USD"> 0 </mdxl:DecreaseInNotePayableResultingFromGainOnForgivenessOfNotePayable>
<mdxl:DecreaseInNotePayableResultingFromGainOnForgivenessOfNotePayable contextRef="From2021-01-012021-06-30" decimals="0" unitRef="USD"> -165719 </mdxl:DecreaseInNotePayableResultingFromGainOnForgivenessOfNotePayable>
<us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="From2022-01-01to2022-06-30">
<p id="xdx_80C_eus-gaap--OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_zauSZ3zmFBke" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><span style="text-decoration: underline">Note 1 - <span id="xdx_828_zNmyFnWpCHai">Organization and Nature of Operation</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc">MediXall Group, Inc. (the "Company “or “MediXall”) was incorporated on December 21, 1998 under the laws of the State of Nevada under the name of IP Gate, Inc. The Company had various name changes since, to reflect changes in the Company’s operating strategies.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc">MediXall Group, Inc. (OTCQB:MDXL) is an innovation-driven technology company purposefully designed and structured around delivering products and services to help consumers learn, decide, and pay for healthcare in ways that complement relationships with trusted doctors. The mission of MediXall Group is to revolutionize the medical industry--improve communication, provide better technology and support services, and provide more efficient, cost-effective healthcare for the consumer. The Company generated minimal revenue in 2022 and 2021 as its online healthcare platform is still in the application and development stage. Further discussion on our operations, mission, and initiatives can be found in the Management’s Discussion and Analysis section of this report.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc">The Company has the following wholly-owned subsidiaries: (1) IHL of Florida, Inc., which is dormant, (2) Medixall Financial Group, which is dormant, (3) Medixaid, Inc., and (4) MediXall.com, Inc., which were established to carry out the development and operation of our healthcare marketplace platform, (5) Health Karma, Inc. which was established in 2020 to increase functionality of the MediXall platform.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc"> </p>
</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
<mdxl:AssetAcquisitionDisclosureTextBlock contextRef="From2022-01-01to2022-06-30">
<p id="xdx_80F_ecustom--AssetAcquisitionDisclosureTextBlock_zHkk1jS9TMIi" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><span style="text-decoration: underline">Note 2 – <span id="xdx_82B_z1c5TG4efL02">Asset Acquisition</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 3pc"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc">On January 17, 2022, the Company entered in agreement to acquire the right to use the intellectual property of 24 Hr Virtual Clinic, LLC (“Virtual Clinic”). In connection with the transaction, the Company issued <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220101__20220117__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember__dei--LegalEntityAxis__custom--MediXallGroupIncMember_pdd" title="Number of shares issued">500,000</span> shares of common stock of MediXall. In accordance with Accounting Standards Codifiation (“ASC”) 805, the value of the stock issued was measured based on an independent appraisal of the rights to use the intellectual property valued at $<span id="xdx_901_ecustom--IntellectualPropertyValue_c20220117_pp0p0" title="Intellectual property value">236,000</span>, which was determined to be the more clearly determinable measure of fair value.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc">Pursuant to the agreement, the Company has the right to buyout the existing members of the Virtual Clinic for an additional <span id="xdx_906_ecustom--AdditionalSharesIssued_c20220101__20220117__dei--LegalEntityAxis__custom--MediXallGroupIncMember_pdd" title="Additional shares issued">500,000</span> shares of MediXall common stock. If this transaction occurs the Virtual Clinic will be renamed to “Wellcare First” and become a wholly-owned subsidiary of the Company.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc">  </p>
</mdxl:AssetAcquisitionDisclosureTextBlock>
<us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2022-01-012022-01-17_us-gaap_CommonStockMember_custom_MediXallGroupIncMember" decimals="INF" unitRef="Shares"> 500000 </us-gaap:StockIssuedDuringPeriodSharesNewIssues>
<mdxl:IntellectualPropertyValue contextRef="AsOf2022-01-17" decimals="0" unitRef="USD"> 236000 </mdxl:IntellectualPropertyValue>
<mdxl:AdditionalSharesIssued contextRef="From2022-01-012022-01-17_custom_MediXallGroupIncMember" decimals="INF" unitRef="Shares"> 500000 </mdxl:AdditionalSharesIssued>
<us-gaap:SubstantialDoubtAboutGoingConcernTextBlock contextRef="From2022-01-01to2022-06-30">
<p id="xdx_803_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_zVNV5eO4WCHi" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><span style="text-decoration: underline">Note 3 – <span id="xdx_829_zUlCHloSRoI4">Going Concern</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc">The Company had an accumulated deficit of $<span id="xdx_908_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pp0p0_di_c20220630_zQADDFAHJ0bh" title="Retained Earnings (Accumulated Deficit)">29,746,486</span> at June 30, 2022, and does not have sufficient operating cash flows. The accompanying condensed consolidated financial statements have been prepared in conformity with generally accepted accounting principles in the United States of America (“GAAP”), which contemplates continuation of the Company as a going concern, which is dependent upon the Company’s ability to establish itself as a profitable business.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc">Since the Company has generated minimal revenues from its planned operations, its ability to continue as a going concern is wholly dependent upon its ability to obtain additional financing. Since inception, the Company has funded operations through short-term borrowings, related party loans, and the proceeds from equity sales in order to meet its strategic objectives. The Company's future operations are dependent upon its ability to generate revenues along with additional external funding as needed. However, there can be no assurance that the Company will be able to obtain sufficient funds to continue the development of its business plan. Subsequent to June 30, 2022, the Company issued $<span id="xdx_90F_eus-gaap--ProceedsFromConvertibleDebt_c20220701__20220823__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zhi51f5YLK25" title="Proceeds from issuance of convertible debentures">375,000 </span>of convertible debentures.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc">In view of these conditions, the ability of the Company to continue as a going concern is in substantial doubt and dependent upon achieving a profitable level of operations and on the ability of the Company to obtain necessary financing to fund ongoing operations. These condensed consolidated financial statements do not give effect to any adjustments which will be necessary should the Company be unable to continue as a going concern and therefore be required to realize its assets and discharge its liabilities in other than the normal course of business and at amounts different from those reflected in the accompanying condensed consolidated financial statements. The condensed consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc">  </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"/>
</us-gaap:SubstantialDoubtAboutGoingConcernTextBlock>
<us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2022-06-30" decimals="0" unitRef="USD"> -29746486 </us-gaap:RetainedEarningsAccumulatedDeficit>
<us-gaap:ProceedsFromConvertibleDebt contextRef="From2022-07-012022-08-23_us-gaap_SubsequentEventMember" decimals="0" unitRef="USD"> 375000 </us-gaap:ProceedsFromConvertibleDebt>
<us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2022-01-01to2022-06-30">
<p id="xdx_809_eus-gaap--SignificantAccountingPoliciesTextBlock_zNA8ndkuXTn" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><span style="text-decoration: underline">Note 4 - <span id="xdx_829_zy7LpoHVsep3">Summary of Significant Accounting Policies</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p id="xdx_847_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_z3Br3HaZ6hkf" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span id="xdx_86E_zg1p8QTjdk01">Basis of Presentation</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc">The accompanying unaudited, condensed consolidated financial statements of the Company have been prepared in accordance with GAAP for interim financial information, and the Securities and Exchange Commission (“SEC”) rules for interim financial reporting. Certain information and footnote disclosures normally included in the condensed consolidated financial statements prepared in accordance with GAAP have been omitted pursuant to such rules and regulations. However, in the opinion of management, the accompanying interim unaudited condensed consolidated financial statements reflect all normal recurring adjustments necessary to present fairly the Company’s condensed consolidated financial position as of June 30, 2022 and the condensed consolidated results of operations and cash flows for the periods presented. The condensed consolidated results of operations for interim periods are not necessarily indicative of the results of operations to be expected for any subsequent interim period or for the fiscal year ending December 31, 2022. The accompanying unaudited condensed consolidated financial statements and notes thereto should be read in conjunction with the audited consolidated financial statements for the year ended December 31, 2021 included in the Company’s Annual Report on Form 10-K, which was filed with the SEC on April 19, 2022.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p id="xdx_841_eus-gaap--ConsolidationPolicyTextBlock_zF1d28wx2ya" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span id="xdx_868_z8tJUp6GGbpd">Principles of Consolidation</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc">These unaudited condensed consolidated financial statements presented are those of the Company and its wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p id="xdx_843_eus-gaap--UseOfEstimates_zsLKgE9NhC23" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span id="xdx_869_zjq03YXxnBI6">Use of Estimates</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc">The preparation of the unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the condensed consolidated financial statements, which management considered in formulating its estimate could change in the near term due to one or more future non-conforming events. Accordingly, the actual results could differ significantly from estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc">A material estimate that is particularly susceptible to significant change in the near-term relate to the determination of the impairment of website and development cost. The Company uses various assumptions it believes to be reasonable under the circumstances to make this estimate. Although considerable variability is likely to be inherent in this estimate, management believes that the amount provided is reasonable. This estimate is continually reviewed and adjusted if necessary. Such adjustments are reflected in current operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p id="xdx_849_eus-gaap--SubsequentEventsPolicyPolicyTextBlock_zrFnacFJTw1e" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span id="xdx_866_zGbQmM7iDJv1">Subsequent Events</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc">Management has evaluated events occurring subsequent to the unaudited condensed consolidated balance sheet date, through August 23 2022, which is the date the unaudited condensed consolidated financial statements were issued, determining all subsequent events have been disclosed.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i> </i></p> <p id="xdx_84A_eus-gaap--ConcentrationRiskCreditRisk_zfPwOyzb95Z2" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span id="xdx_868_zw1GQ4C2sfp6">Risks and Uncertainties</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc">The Company's operations are subject to significant risks and uncertainties including financial, operational and regulatory risks, including the potential risk of business failure. Additionally, the Company faces significant risk and uncertainty related to the coronavirus global pandemic (“COVID-19”) pandemic.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p id="xdx_84F_eus-gaap--IncomeTaxPolicyTextBlock_zeVWQcL2YSL3" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span id="xdx_860_z5STkG3bxXvb">Income Taxes</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc">The Company accounts for income taxes using the liability method prescribed by the Financial Accounting Standards Board’s (the “FASB”) Accounting Standards Codification 740, "Income Taxes". Under this method, deferred tax assets and liabilities are determined based on the difference between the financial reporting and tax bases of assets and liabilities using enacted tax rates that will be in effect in the year in which the differences are expected to reverse. The Company records a valuation allowance to offset deferred tax assets if based on the weight of available evidence, it is more-likely-than-not that some portion, or all, of the deferred tax assets will not be realized. The effect on deferred taxes of a change in tax rates is recognized as income or loss in the year that includes the enactment date.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc">Pursuant to accounting standards related to the accounting for uncertainty in income taxes, the evaluation of a tax position is a two-step process. The first step is to determine whether it is more likely than not that a tax position will be sustained upon examination, including the resolution of any related appeals or litigation based on the technical merits of that position. The second step is to measure a tax position that meets the more- likely-than-not threshold to determine the amount of benefit to be recognized in the financial statements. A tax position is measured at the largest amount of benefit that is greater than 50% likelihood of being realized upon ultimate settlement. Tax positions that previously failed to meet the more-likely-than -not recognition threshold should be recognized in the first subsequent period in which the threshold is met. Previously recognized tax positions that no longer meet the more-likely-than-not criteria should be de- recognized in the first subsequent financial reporting period in which the threshold is no longer met. The accounting standard also provides guidance on de- recognition, classification, interest and penalties, accounting in interim periods, disclosures, and transition.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc">The Company assessed its earnings history, trends, and estimates of future earnings, and determined that the deferred tax asset could not be realized as of June 30, 2022. Accordingly, a valuation allowance was recorded against the net deferred tax asset.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p id="xdx_84C_eus-gaap--RevenueRecognitionPolicyTextBlock_zfghBAW8Fr63" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span id="xdx_869_zM3EJqXNsatd">Revenue Recognition</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc">The Company accounts for revenue in accordance with Accounting Standards Updated ("ASU") ASU 2014-09 Revenue from Contracts with Customers and all subsequent amendments to the ASU (collectively, "ASC 606"). The Company had minimal revenues in 2022 and in 2021. The Company recognizes revenue in accordance with ASC 606, the core principle of which is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled to receive in exchange for those goods or services. To achieve this core principle, five basic criteria must be met before revenue can be recognized: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to performance obligations in the contract; and (5) recognize revenue when or as the Company satisfies a performance obligation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc">In 2022 and 2021, the Company generated revenues from selling bundle medical and wellness services to individuals, employer groups, or third-party administrators from the Company’s Health Karma platform. The Company primarily generates revenue from employer customers and consumer subscription fees, which are typically a 12-month commitment in nature. Through our per-Member-per-month (“PMPM”) subscription model, we enter into contracts with our employer customers that pay a fixed monthly rate based on the total number of members. In most cases, members and their dependents have unlimited access to our platform and do not pay extra fees for increased utilization, unless they wish to access services outside the scope of those covered by the subscription.  Our performance obligations are satisfied overtime as we provide access to the Health Karma portal and associated benefits. We recognize revenue monthly as the services are rendered and performance obligations are satisfied.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc"> </p> <p id="xdx_842_ecustom--SeniorConvertibleDebenturesAndWarrantsPolicyTextBlock_zxV8u7OnHaeh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_86C_zIitAZ4hSpsb">Senior Convertible Debentures and Warrants</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc">The senior convertible debentures (Convertible Debt) is recorded at its fair value, limited to a relative fair value based upon the percentage of its fair value to the total fair value including the fair value of the warrant.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc">Warrants issued with the Convertible Debt are accounted for under the fair value and relative fair value method. The warrant is first analyzed per its terms as to whether it has derivative features or not. The warrant was determined to not have derivative features, and was recorded into equity at its fair value using the Black Scholes option model, however, limited to a relative fair value based upon the percentage of its fair value to the total fair value including the fair value of the Convertible Debt. The warrants relative fair values is recorded as a discount to the Convertible Debt and as additional paid-in-capital. Discount on the Convertible Debt is amortized to interest expense over the life of the debt.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i> </i></p> <p id="xdx_847_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zOH97xZeupTg" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span id="xdx_863_zU1fIKN8wNLk">Share-Based Payment Arrangements</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc">The Company applies the fair value method in accounting for its stock-based compensation. This standard states that compensation cost is measured at the grant date based on the fair value of the award and is recognized over the service period, which is usually the vesting period. The Company values the stock-based compensation at the market price for the Company's stock as of the date of issuance.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i> </i></p> <p id="xdx_84B_eus-gaap--EarningsPerSharePolicyTextBlock_zyzCocQj0bM6" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span id="xdx_866_zu1XNteO1tNf">Loss Per Share</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc">The computation of basic loss per share (“LPS”) is based on the weighted average number of shares that were outstanding during the periods, including shares of common stock that are issuable at the end of the reporting period. The computation of diluted LPS is based on the number of basic weighted-average shares outstanding. The computation of diluted LPS does not assume conversion, exercise or contingent issuance of securities that would have an antidilutive effect on LPS. Therefore, when calculating LPS, there is no inclusion of dilutive securities as their inclusion in the LPS calculation is antidilutive due to net loss for the periods.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc">Following is the computation of basic and diluted loss per share for the three and six months periods ended June 30, 2022 and 2021:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc"> </p> <table cellpadding="0" cellspacing="0" id="xdx_889_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zNM21ck0xIT6" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of Significant Accounting Policies (Schedule of Basic and Diluted EPS) (Details)"> <tr style="vertical-align: bottom; background-color: transparent"> <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.5pc; padding-left: 0.5pc"><span id="xdx_8B9_zQAxgh4gSGlj" style="display: none">Schedule of computation of basic and diluted net loss per share</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_492_20220401__20220630_zLRUbvSOGJ48" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_497_20210401__20210630_z38J2i5fNiif" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_491_20220101__20220630_zz2fSZ1ZlASj" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49C_20210101__20210630_z0PLENy30Ri" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 8pt"> </td><td style="font: bold 8pt Times New Roman, Times, Serif"> </td> <td colspan="6" style="font: bold 8pt Times New Roman, Times, Serif; text-align: center">Three Months Ended</td><td style="font: bold 8pt Times New Roman, Times, Serif"> </td><td style="font: bold 8pt Times New Roman, Times, Serif"> </td> <td colspan="6" style="font: bold 8pt Times New Roman, Times, Serif; text-align: center">Six Months Ended</td><td style="font: bold 8pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 8pt"> </td><td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center">June 30,</td><td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td><td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center">June 30,</td><td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 8pt"> </td><td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td><td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td><td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td><td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td></tr> <tr id="xdx_407_ecustom--EarningsPerSharesBasicAndDilutedAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -0.5pc; padding-left: 0.5pc">Basic and Diluted LPS Computation</td><td style="font: 11pt Calibri, Helvetica, Sans-Serif"> </td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left"> </td><td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: right"> </td><td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left"> </td><td style="font: 11pt Calibri, Helvetica, Sans-Serif"> </td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left"> </td><td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: right"> </td><td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left"> </td><td style="font: 11pt Calibri, Helvetica, Sans-Serif"> </td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left"> </td><td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: right"> </td><td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left"> </td><td style="font: 11pt Calibri, Helvetica, Sans-Serif"> </td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left"> </td><td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: right"> </td><td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left"> </td></tr> <tr id="xdx_40E_ecustom--NumeratorAbstract_i01B" style="vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.5pc; padding-left: 0.5pc">Numerator:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_i02_pp0p0" style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 48%; text-align: left; text-indent: -0.5pc; padding-left: 0.5pc">Net loss</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">(1,553,994</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">(1,659,216</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">(3,964,096</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">(2,991,517</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td></tr> <tr id="xdx_403_eus-gaap--DividendsPreferredStockStock_i02_pp0p0" style="vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; text-indent: -0.5pc; padding-left: 0.5pc">Series B Preferred Stock Dividends</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">73,649</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">59,687</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">146,488</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">106,656</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_401_ecustom--LossAvailableToCommonStockholders_i02_pp0p0" style="vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; text-indent: -0.5pc; padding-left: 0.5pc">Loss available to common stockholders</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(1,627,643</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(1,718,903</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(4,110,584</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(3,098,173</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_404_ecustom--DenominatorAbstract_i01B" style="vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.5pc; padding-left: 0.5pc">Denominator:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_401_ecustom--WeightedAverageNumberOfCommonSharesOutstanding_i01_zgPjRnY20nA9" style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; text-indent: -0.5pc; padding-left: 0.5pc">Weighted average number of common shares outstanding</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">116,151,261</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">102,075,557</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">115,392,749</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">101,177,844</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.5pc; padding-left: 0.5pc"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_406_ecustom--BasicAndDilutedLps_i01_zu8e37JqWQAj" style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-indent: -0.5pc; padding-left: 0.5pc">Basic and diluted LPS</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(0.01</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(0.02</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(0.04</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(0.03</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc">Potentially dilutive securities not included in the calculation of diluted LPS attributable to common stockholders because to do so would be anti-dilutive are as follows (in common stock equivalent shares):</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_892_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_z3YbpoqGo02i" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of Significant Accounting Policies (Schedule of potentially dilutive securities) (Details)"> <tr style="vertical-align: bottom; background-color: transparent"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_8B3_zflT2rFWMpdg" style="display: none">Schedule of potentially dilutive securities not included in the calculation of diluted net loss per share</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 48%; text-align: left">Series A Preferred stock (convertible)</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_98D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220401__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_z2FQtpEWdnDh" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Anti-dilutive securities">24,900,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_988_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210401__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zYESRxtUe19b" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Anti-dilutive securities">24,900,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_983_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_pdd" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Anti-dilutive securities">24,900,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_98D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_pdd" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Anti-dilutive securities">24,900,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: transparent"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Series B Preferred stock (convertible)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220401__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zEGOiQ3z6HY8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Anti-dilutive securities">15,637,490</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_982_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210401__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zGlhEWCNNRqe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Anti-dilutive securities">11,937,440</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_980_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Anti-dilutive securities">15,637,440</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_982_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Anti-dilutive securities">11,937,440</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Senior Convertible Debentures and Warrants</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_980_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220401__20220630__us-gaap--StatementClassOfStockAxis__custom--SeniorConvertibleDebenturesAndWarrantsMember_zXwaJRX1Nt3g" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Anti-dilutive securities">1,233,625</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_980_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d0_c20210401__20210630__us-gaap--StatementClassOfStockAxis__custom--SeniorConvertibleDebenturesAndWarrantsMember_zW0cu8KNjNq4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Anti-dilutive securities">—</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20220630__us-gaap--StatementClassOfStockAxis__custom--SeniorConvertibleDebenturesAndWarrantsMember_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Anti-dilutive securities">1,616,125</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d0_c20210101__20210630__us-gaap--StatementClassOfStockAxis__custom--SeniorConvertibleDebenturesAndWarrantsMember_zjMcn1N5ur11" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Anti-dilutive securities">—</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> </table> <p id="xdx_8A3_zJSE7kjJ2N01" style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 3pc"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i> </i></p> <p id="xdx_84F_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zHQ9zSmfb9P7" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span id="xdx_86B_zQsy0JqsZtPd">Recoverability of Long-Lived Assets</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc">The Company assesses the recoverability of long-lived assets annually or whenever events or changes in circumstances indicate that expected future undiscounted cash flows might not be sufficient to support the carrying amount of an asset. The Company deems an asset to be impaired if a forecast of undiscounted future operating cash flows is less than the carrying amount. If an asset is determined to be impaired, the loss is measured as the amount by which the carrying value of the asset exceeds its fair value. There was <span id="xdx_90C_eus-gaap--ImpairmentOfLongLivedAssetsHeldForUse_do_c20220401__20220630_zhxRMMS1tfzf" title="Impairment of long-lived assets"><span id="xdx_900_eus-gaap--ImpairmentOfLongLivedAssetsHeldForUse_do_c20220101__20220630_zTqvP58OGsrk" title="Impairment of long-lived assets"><span id="xdx_904_eus-gaap--ImpairmentOfLongLivedAssetsHeldForUse_do_c20210401__20210630_zwNrC3wwQ9Si" title="Impairment of long-lived assets"><span id="xdx_90E_eus-gaap--ImpairmentOfLongLivedAssetsHeldForUse_do_c20210101__20210630_zQ7Nc68N5Ifj" title="Impairment of long-lived assets">no</span></span></span></span> impairment of long-lived assets pertaining to the three and six months periods ended June 30, 2022 and 2021. However, there can be no assurances that future impairment tests will not result in a charge to operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">   </p> <p id="xdx_844_ecustom--RightsToUseIntellectualPropertyPolicyTextBlock_zlfHSkDDLOSh" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span id="xdx_86C_zFSxSVulZbN2">Rights-to-use Intellectual Property</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The rights-to-use intellectual property (“Intellectual Property”) is an intangible asset arising from the Company’s right to use the proprietary technology and programs of the Virtual Clinic. The Intellectual Property was initially measured at fair value and will be amortized on a straightline basis over its estimated useful life as the economic benefits are consumed or otherwise realized. Management has determined the estimated useful life to be seven years.</p> <p id="xdx_84A_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_zwdH0vBS2lgc" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span id="xdx_869_zj2E5eMy8cH6">Website and Development Costs</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc">Internal and external costs incurred to develop, the internal-use computer software during the application and development stage shall be capitalized subsequent to the preliminary project stage and when it is probable that the project will be completed. As of June 30, 2022 and December 31, 2021, the Company has met the capitalization requirements and has incurred $<span id="xdx_903_eus-gaap--CapitalizedComputerSoftwareNet_iI_pp0p0_c20220630_zrZVj9t0YLqh" title="Website and development costs"><span id="xdx_903_eus-gaap--CapitalizedComputerSoftwareNet_iI_pp0p0_c20211231_z5GYeekGFI8k" title="Website and development costs">451,404</span></span> at both periods, in costs related to the development of the MediXall platform. Upon completion, the related assets will be amortized over the estimated useful life of the underlying product. The Company will amortize the cost of the intangible asset using amortization methods that reflect the pattern in which the economic benefits of the intangible asset are consumed or otherwise realized.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b> </b></p> <p id="xdx_845_eus-gaap--ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_zsVaitI9I69l" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_868_zB4DhTsYTKU2">Allowance for Uncollectible Accounts Receivable</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc">An allowance for uncollectible accounts receivable is recorded when management believes the uncollectability of the accounts receivable is confirmed. Subsequent recoveries, if any, are credited to the allowance. The allowance is determined based on management’s review of the debtor’s ability to repay and repayment history, aging history, and estimated value of collateral, if any.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc"> </p> <p id="xdx_842_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_znaB1SMDhIyc" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span id="xdx_86E_z1eXj39kUwP4">Recent Accounting Pronouncements</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 3pc">Management does not believe that any recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company’s consolidated financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc"> <b> </b></p>
</us-gaap:SignificantAccountingPoliciesTextBlock>
<us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="From2022-01-01to2022-06-30">
<p id="xdx_847_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_z3Br3HaZ6hkf" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span id="xdx_86E_zg1p8QTjdk01">Basis of Presentation</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc">The accompanying unaudited, condensed consolidated financial statements of the Company have been prepared in accordance with GAAP for interim financial information, and the Securities and Exchange Commission (“SEC”) rules for interim financial reporting. Certain information and footnote disclosures normally included in the condensed consolidated financial statements prepared in accordance with GAAP have been omitted pursuant to such rules and regulations. However, in the opinion of management, the accompanying interim unaudited condensed consolidated financial statements reflect all normal recurring adjustments necessary to present fairly the Company’s condensed consolidated financial position as of June 30, 2022 and the condensed consolidated results of operations and cash flows for the periods presented. The condensed consolidated results of operations for interim periods are not necessarily indicative of the results of operations to be expected for any subsequent interim period or for the fiscal year ending December 31, 2022. The accompanying unaudited condensed consolidated financial statements and notes thereto should be read in conjunction with the audited consolidated financial statements for the year ended December 31, 2021 included in the Company’s Annual Report on Form 10-K, which was filed with the SEC on April 19, 2022.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p>
</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
<us-gaap:ConsolidationPolicyTextBlock contextRef="From2022-01-01to2022-06-30">
<p id="xdx_841_eus-gaap--ConsolidationPolicyTextBlock_zF1d28wx2ya" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span id="xdx_868_z8tJUp6GGbpd">Principles of Consolidation</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc">These unaudited condensed consolidated financial statements presented are those of the Company and its wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p>
</us-gaap:ConsolidationPolicyTextBlock>
<us-gaap:UseOfEstimates contextRef="From2022-01-01to2022-06-30">
<p id="xdx_843_eus-gaap--UseOfEstimates_zsLKgE9NhC23" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span id="xdx_869_zjq03YXxnBI6">Use of Estimates</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc">The preparation of the unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the condensed consolidated financial statements, which management considered in formulating its estimate could change in the near term due to one or more future non-conforming events. Accordingly, the actual results could differ significantly from estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc">A material estimate that is particularly susceptible to significant change in the near-term relate to the determination of the impairment of website and development cost. The Company uses various assumptions it believes to be reasonable under the circumstances to make this estimate. Although considerable variability is likely to be inherent in this estimate, management believes that the amount provided is reasonable. This estimate is continually reviewed and adjusted if necessary. Such adjustments are reflected in current operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p>
</us-gaap:UseOfEstimates>
<us-gaap:SubsequentEventsPolicyPolicyTextBlock contextRef="From2022-01-01to2022-06-30">
<p id="xdx_849_eus-gaap--SubsequentEventsPolicyPolicyTextBlock_zrFnacFJTw1e" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span id="xdx_866_zGbQmM7iDJv1">Subsequent Events</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc">Management has evaluated events occurring subsequent to the unaudited condensed consolidated balance sheet date, through August 23 2022, which is the date the unaudited condensed consolidated financial statements were issued, determining all subsequent events have been disclosed.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i> </i></p>
</us-gaap:SubsequentEventsPolicyPolicyTextBlock>
<us-gaap:ConcentrationRiskCreditRisk contextRef="From2022-01-01to2022-06-30">
<p id="xdx_84A_eus-gaap--ConcentrationRiskCreditRisk_zfPwOyzb95Z2" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span id="xdx_868_zw1GQ4C2sfp6">Risks and Uncertainties</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc">The Company's operations are subject to significant risks and uncertainties including financial, operational and regulatory risks, including the potential risk of business failure. Additionally, the Company faces significant risk and uncertainty related to the coronavirus global pandemic (“COVID-19”) pandemic.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p>
</us-gaap:ConcentrationRiskCreditRisk>
<us-gaap:IncomeTaxPolicyTextBlock contextRef="From2022-01-01to2022-06-30">
<p id="xdx_84F_eus-gaap--IncomeTaxPolicyTextBlock_zeVWQcL2YSL3" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span id="xdx_860_z5STkG3bxXvb">Income Taxes</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc">The Company accounts for income taxes using the liability method prescribed by the Financial Accounting Standards Board’s (the “FASB”) Accounting Standards Codification 740, "Income Taxes". Under this method, deferred tax assets and liabilities are determined based on the difference between the financial reporting and tax bases of assets and liabilities using enacted tax rates that will be in effect in the year in which the differences are expected to reverse. The Company records a valuation allowance to offset deferred tax assets if based on the weight of available evidence, it is more-likely-than-not that some portion, or all, of the deferred tax assets will not be realized. The effect on deferred taxes of a change in tax rates is recognized as income or loss in the year that includes the enactment date.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc">Pursuant to accounting standards related to the accounting for uncertainty in income taxes, the evaluation of a tax position is a two-step process. The first step is to determine whether it is more likely than not that a tax position will be sustained upon examination, including the resolution of any related appeals or litigation based on the technical merits of that position. The second step is to measure a tax position that meets the more- likely-than-not threshold to determine the amount of benefit to be recognized in the financial statements. A tax position is measured at the largest amount of benefit that is greater than 50% likelihood of being realized upon ultimate settlement. Tax positions that previously failed to meet the more-likely-than -not recognition threshold should be recognized in the first subsequent period in which the threshold is met. Previously recognized tax positions that no longer meet the more-likely-than-not criteria should be de- recognized in the first subsequent financial reporting period in which the threshold is no longer met. The accounting standard also provides guidance on de- recognition, classification, interest and penalties, accounting in interim periods, disclosures, and transition.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc">The Company assessed its earnings history, trends, and estimates of future earnings, and determined that the deferred tax asset could not be realized as of June 30, 2022. Accordingly, a valuation allowance was recorded against the net deferred tax asset.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p>
</us-gaap:IncomeTaxPolicyTextBlock>
<us-gaap:RevenueRecognitionPolicyTextBlock contextRef="From2022-01-01to2022-06-30">
<p id="xdx_84C_eus-gaap--RevenueRecognitionPolicyTextBlock_zfghBAW8Fr63" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span id="xdx_869_zM3EJqXNsatd">Revenue Recognition</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc">The Company accounts for revenue in accordance with Accounting Standards Updated ("ASU") ASU 2014-09 Revenue from Contracts with Customers and all subsequent amendments to the ASU (collectively, "ASC 606"). The Company had minimal revenues in 2022 and in 2021. The Company recognizes revenue in accordance with ASC 606, the core principle of which is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled to receive in exchange for those goods or services. To achieve this core principle, five basic criteria must be met before revenue can be recognized: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to performance obligations in the contract; and (5) recognize revenue when or as the Company satisfies a performance obligation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc">In 2022 and 2021, the Company generated revenues from selling bundle medical and wellness services to individuals, employer groups, or third-party administrators from the Company’s Health Karma platform. The Company primarily generates revenue from employer customers and consumer subscription fees, which are typically a 12-month commitment in nature. Through our per-Member-per-month (“PMPM”) subscription model, we enter into contracts with our employer customers that pay a fixed monthly rate based on the total number of members. In most cases, members and their dependents have unlimited access to our platform and do not pay extra fees for increased utilization, unless they wish to access services outside the scope of those covered by the subscription.  Our performance obligations are satisfied overtime as we provide access to the Health Karma portal and associated benefits. We recognize revenue monthly as the services are rendered and performance obligations are satisfied.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc"> </p>
</us-gaap:RevenueRecognitionPolicyTextBlock>
<mdxl:SeniorConvertibleDebenturesAndWarrantsPolicyTextBlock contextRef="From2022-01-01to2022-06-30">
<p id="xdx_842_ecustom--SeniorConvertibleDebenturesAndWarrantsPolicyTextBlock_zxV8u7OnHaeh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_86C_zIitAZ4hSpsb">Senior Convertible Debentures and Warrants</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc">The senior convertible debentures (Convertible Debt) is recorded at its fair value, limited to a relative fair value based upon the percentage of its fair value to the total fair value including the fair value of the warrant.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc">Warrants issued with the Convertible Debt are accounted for under the fair value and relative fair value method. The warrant is first analyzed per its terms as to whether it has derivative features or not. The warrant was determined to not have derivative features, and was recorded into equity at its fair value using the Black Scholes option model, however, limited to a relative fair value based upon the percentage of its fair value to the total fair value including the fair value of the Convertible Debt. The warrants relative fair values is recorded as a discount to the Convertible Debt and as additional paid-in-capital. Discount on the Convertible Debt is amortized to interest expense over the life of the debt.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i> </i></p>
</mdxl:SeniorConvertibleDebenturesAndWarrantsPolicyTextBlock>
<us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="From2022-01-01to2022-06-30">
<p id="xdx_847_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zOH97xZeupTg" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span id="xdx_863_zU1fIKN8wNLk">Share-Based Payment Arrangements</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc">The Company applies the fair value method in accounting for its stock-based compensation. This standard states that compensation cost is measured at the grant date based on the fair value of the award and is recognized over the service period, which is usually the vesting period. The Company values the stock-based compensation at the market price for the Company's stock as of the date of issuance.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i> </i></p>
</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
<us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2022-01-01to2022-06-30">
<p id="xdx_84B_eus-gaap--EarningsPerSharePolicyTextBlock_zyzCocQj0bM6" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span id="xdx_866_zu1XNteO1tNf">Loss Per Share</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc">The computation of basic loss per share (“LPS”) is based on the weighted average number of shares that were outstanding during the periods, including shares of common stock that are issuable at the end of the reporting period. The computation of diluted LPS is based on the number of basic weighted-average shares outstanding. The computation of diluted LPS does not assume conversion, exercise or contingent issuance of securities that would have an antidilutive effect on LPS. Therefore, when calculating LPS, there is no inclusion of dilutive securities as their inclusion in the LPS calculation is antidilutive due to net loss for the periods.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc">Following is the computation of basic and diluted loss per share for the three and six months periods ended June 30, 2022 and 2021:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc"> </p> <table cellpadding="0" cellspacing="0" id="xdx_889_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zNM21ck0xIT6" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of Significant Accounting Policies (Schedule of Basic and Diluted EPS) (Details)"> <tr style="vertical-align: bottom; background-color: transparent"> <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.5pc; padding-left: 0.5pc"><span id="xdx_8B9_zQAxgh4gSGlj" style="display: none">Schedule of computation of basic and diluted net loss per share</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_492_20220401__20220630_zLRUbvSOGJ48" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_497_20210401__20210630_z38J2i5fNiif" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_491_20220101__20220630_zz2fSZ1ZlASj" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49C_20210101__20210630_z0PLENy30Ri" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 8pt"> </td><td style="font: bold 8pt Times New Roman, Times, Serif"> </td> <td colspan="6" style="font: bold 8pt Times New Roman, Times, Serif; text-align: center">Three Months Ended</td><td style="font: bold 8pt Times New Roman, Times, Serif"> </td><td style="font: bold 8pt Times New Roman, Times, Serif"> </td> <td colspan="6" style="font: bold 8pt Times New Roman, Times, Serif; text-align: center">Six Months Ended</td><td style="font: bold 8pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 8pt"> </td><td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center">June 30,</td><td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td><td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center">June 30,</td><td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 8pt"> </td><td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td><td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td><td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td><td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td></tr> <tr id="xdx_407_ecustom--EarningsPerSharesBasicAndDilutedAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -0.5pc; padding-left: 0.5pc">Basic and Diluted LPS Computation</td><td style="font: 11pt Calibri, Helvetica, Sans-Serif"> </td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left"> </td><td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: right"> </td><td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left"> </td><td style="font: 11pt Calibri, Helvetica, Sans-Serif"> </td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left"> </td><td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: right"> </td><td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left"> </td><td style="font: 11pt Calibri, Helvetica, Sans-Serif"> </td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left"> </td><td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: right"> </td><td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left"> </td><td style="font: 11pt Calibri, Helvetica, Sans-Serif"> </td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left"> </td><td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: right"> </td><td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left"> </td></tr> <tr id="xdx_40E_ecustom--NumeratorAbstract_i01B" style="vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.5pc; padding-left: 0.5pc">Numerator:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_i02_pp0p0" style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 48%; text-align: left; text-indent: -0.5pc; padding-left: 0.5pc">Net loss</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">(1,553,994</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">(1,659,216</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">(3,964,096</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">(2,991,517</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td></tr> <tr id="xdx_403_eus-gaap--DividendsPreferredStockStock_i02_pp0p0" style="vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; text-indent: -0.5pc; padding-left: 0.5pc">Series B Preferred Stock Dividends</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">73,649</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">59,687</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">146,488</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">106,656</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_401_ecustom--LossAvailableToCommonStockholders_i02_pp0p0" style="vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; text-indent: -0.5pc; padding-left: 0.5pc">Loss available to common stockholders</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(1,627,643</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(1,718,903</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(4,110,584</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(3,098,173</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_404_ecustom--DenominatorAbstract_i01B" style="vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.5pc; padding-left: 0.5pc">Denominator:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_401_ecustom--WeightedAverageNumberOfCommonSharesOutstanding_i01_zgPjRnY20nA9" style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; text-indent: -0.5pc; padding-left: 0.5pc">Weighted average number of common shares outstanding</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">116,151,261</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">102,075,557</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">115,392,749</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">101,177,844</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.5pc; padding-left: 0.5pc"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_406_ecustom--BasicAndDilutedLps_i01_zu8e37JqWQAj" style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-indent: -0.5pc; padding-left: 0.5pc">Basic and diluted LPS</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(0.01</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(0.02</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(0.04</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(0.03</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc">Potentially dilutive securities not included in the calculation of diluted LPS attributable to common stockholders because to do so would be anti-dilutive are as follows (in common stock equivalent shares):</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_892_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_z3YbpoqGo02i" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of Significant Accounting Policies (Schedule of potentially dilutive securities) (Details)"> <tr style="vertical-align: bottom; background-color: transparent"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_8B3_zflT2rFWMpdg" style="display: none">Schedule of potentially dilutive securities not included in the calculation of diluted net loss per share</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 48%; text-align: left">Series A Preferred stock (convertible)</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_98D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220401__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_z2FQtpEWdnDh" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Anti-dilutive securities">24,900,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_988_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210401__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zYESRxtUe19b" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Anti-dilutive securities">24,900,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_983_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_pdd" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Anti-dilutive securities">24,900,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_98D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_pdd" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Anti-dilutive securities">24,900,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: transparent"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Series B Preferred stock (convertible)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220401__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zEGOiQ3z6HY8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Anti-dilutive securities">15,637,490</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_982_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210401__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zGlhEWCNNRqe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Anti-dilutive securities">11,937,440</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_980_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Anti-dilutive securities">15,637,440</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_982_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Anti-dilutive securities">11,937,440</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Senior Convertible Debentures and Warrants</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_980_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220401__20220630__us-gaap--StatementClassOfStockAxis__custom--SeniorConvertibleDebenturesAndWarrantsMember_zXwaJRX1Nt3g" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Anti-dilutive securities">1,233,625</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_980_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d0_c20210401__20210630__us-gaap--StatementClassOfStockAxis__custom--SeniorConvertibleDebenturesAndWarrantsMember_zW0cu8KNjNq4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Anti-dilutive securities">—</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20220630__us-gaap--StatementClassOfStockAxis__custom--SeniorConvertibleDebenturesAndWarrantsMember_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Anti-dilutive securities">1,616,125</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d0_c20210101__20210630__us-gaap--StatementClassOfStockAxis__custom--SeniorConvertibleDebenturesAndWarrantsMember_zjMcn1N5ur11" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Anti-dilutive securities">—</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> </table> <p id="xdx_8A3_zJSE7kjJ2N01" style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 3pc"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i> </i></p>
</us-gaap:EarningsPerSharePolicyTextBlock>
<us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="From2022-01-01to2022-06-30">
<table cellpadding="0" cellspacing="0" id="xdx_889_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zNM21ck0xIT6" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of Significant Accounting Policies (Schedule of Basic and Diluted EPS) (Details)"> <tr style="vertical-align: bottom; background-color: transparent"> <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.5pc; padding-left: 0.5pc"><span id="xdx_8B9_zQAxgh4gSGlj" style="display: none">Schedule of computation of basic and diluted net loss per share</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_492_20220401__20220630_zLRUbvSOGJ48" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_497_20210401__20210630_z38J2i5fNiif" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_491_20220101__20220630_zz2fSZ1ZlASj" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49C_20210101__20210630_z0PLENy30Ri" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 8pt"> </td><td style="font: bold 8pt Times New Roman, Times, Serif"> </td> <td colspan="6" style="font: bold 8pt Times New Roman, Times, Serif; text-align: center">Three Months Ended</td><td style="font: bold 8pt Times New Roman, Times, Serif"> </td><td style="font: bold 8pt Times New Roman, Times, Serif"> </td> <td colspan="6" style="font: bold 8pt Times New Roman, Times, Serif; text-align: center">Six Months Ended</td><td style="font: bold 8pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 8pt"> </td><td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center">June 30,</td><td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td><td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center">June 30,</td><td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 8pt"> </td><td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td><td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td><td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td><td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: bold 8pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td></tr> <tr id="xdx_407_ecustom--EarningsPerSharesBasicAndDilutedAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -0.5pc; padding-left: 0.5pc">Basic and Diluted LPS Computation</td><td style="font: 11pt Calibri, Helvetica, Sans-Serif"> </td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left"> </td><td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: right"> </td><td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left"> </td><td style="font: 11pt Calibri, Helvetica, Sans-Serif"> </td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left"> </td><td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: right"> </td><td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left"> </td><td style="font: 11pt Calibri, Helvetica, Sans-Serif"> </td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left"> </td><td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: right"> </td><td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left"> </td><td style="font: 11pt Calibri, Helvetica, Sans-Serif"> </td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left"> </td><td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: right"> </td><td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left"> </td></tr> <tr id="xdx_40E_ecustom--NumeratorAbstract_i01B" style="vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.5pc; padding-left: 0.5pc">Numerator:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_i02_pp0p0" style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 48%; text-align: left; text-indent: -0.5pc; padding-left: 0.5pc">Net loss</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">(1,553,994</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">(1,659,216</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">(3,964,096</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">(2,991,517</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td></tr> <tr id="xdx_403_eus-gaap--DividendsPreferredStockStock_i02_pp0p0" style="vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; text-indent: -0.5pc; padding-left: 0.5pc">Series B Preferred Stock Dividends</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">73,649</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">59,687</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">146,488</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">106,656</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_401_ecustom--LossAvailableToCommonStockholders_i02_pp0p0" style="vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; text-indent: -0.5pc; padding-left: 0.5pc">Loss available to common stockholders</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(1,627,643</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(1,718,903</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(4,110,584</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(3,098,173</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_404_ecustom--DenominatorAbstract_i01B" style="vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.5pc; padding-left: 0.5pc">Denominator:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_401_ecustom--WeightedAverageNumberOfCommonSharesOutstanding_i01_zgPjRnY20nA9" style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; text-indent: -0.5pc; padding-left: 0.5pc">Weighted average number of common shares outstanding</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">116,151,261</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">102,075,557</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">115,392,749</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">101,177,844</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.5pc; padding-left: 0.5pc"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_406_ecustom--BasicAndDilutedLps_i01_zu8e37JqWQAj" style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-indent: -0.5pc; padding-left: 0.5pc">Basic and diluted LPS</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(0.01</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(0.02</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(0.04</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(0.03</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td></tr> </table>
</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
<us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted contextRef="From2022-04-012022-06-30" decimals="0" unitRef="USD"> -1553994 </us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
<us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted contextRef="From2021-04-012021-06-30" decimals="0" unitRef="USD"> -1659216 </us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
<us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted contextRef="From2022-01-01to2022-06-30" decimals="0" unitRef="USD"> -3964096 </us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
<us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted contextRef="From2021-01-012021-06-30" decimals="0" unitRef="USD"> -2991517 </us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
<us-gaap:DividendsPreferredStockStock contextRef="From2022-04-012022-06-30" decimals="0" unitRef="USD"> 73649 </us-gaap:DividendsPreferredStockStock>
<us-gaap:DividendsPreferredStockStock contextRef="From2021-04-012021-06-30" decimals="0" unitRef="USD"> 59687 </us-gaap:DividendsPreferredStockStock>
<us-gaap:DividendsPreferredStockStock contextRef="From2022-01-01to2022-06-30" decimals="0" unitRef="USD"> 146488 </us-gaap:DividendsPreferredStockStock>
<us-gaap:DividendsPreferredStockStock contextRef="From2021-01-012021-06-30" decimals="0" unitRef="USD"> 106656 </us-gaap:DividendsPreferredStockStock>
<mdxl:LossAvailableToCommonStockholders contextRef="From2022-04-012022-06-30" decimals="0" unitRef="USD"> -1627643 </mdxl:LossAvailableToCommonStockholders>
<mdxl:LossAvailableToCommonStockholders contextRef="From2021-04-012021-06-30" decimals="0" unitRef="USD"> -1718903 </mdxl:LossAvailableToCommonStockholders>
<mdxl:LossAvailableToCommonStockholders contextRef="From2022-01-01to2022-06-30" decimals="0" unitRef="USD"> -4110584 </mdxl:LossAvailableToCommonStockholders>
<mdxl:LossAvailableToCommonStockholders contextRef="From2021-01-012021-06-30" decimals="0" unitRef="USD"> -3098173 </mdxl:LossAvailableToCommonStockholders>
<mdxl:WeightedAverageNumberOfCommonSharesOutstanding contextRef="From2022-04-012022-06-30" decimals="INF" unitRef="Shares"> 116151261 </mdxl:WeightedAverageNumberOfCommonSharesOutstanding>
<mdxl:WeightedAverageNumberOfCommonSharesOutstanding contextRef="From2021-04-012021-06-30" decimals="INF" unitRef="Shares"> 102075557 </mdxl:WeightedAverageNumberOfCommonSharesOutstanding>
<mdxl:WeightedAverageNumberOfCommonSharesOutstanding contextRef="From2022-01-01to2022-06-30" decimals="INF" unitRef="Shares"> 115392749 </mdxl:WeightedAverageNumberOfCommonSharesOutstanding>
<mdxl:WeightedAverageNumberOfCommonSharesOutstanding contextRef="From2021-01-012021-06-30" decimals="INF" unitRef="Shares"> 101177844 </mdxl:WeightedAverageNumberOfCommonSharesOutstanding>
<mdxl:BasicAndDilutedLps contextRef="From2022-04-012022-06-30" decimals="INF" unitRef="Shares"> -0.01 </mdxl:BasicAndDilutedLps>
<mdxl:BasicAndDilutedLps contextRef="From2021-04-012021-06-30" decimals="INF" unitRef="Shares"> -0.02 </mdxl:BasicAndDilutedLps>
<mdxl:BasicAndDilutedLps contextRef="From2022-01-01to2022-06-30" decimals="INF" unitRef="Shares"> -0.04 </mdxl:BasicAndDilutedLps>
<mdxl:BasicAndDilutedLps contextRef="From2021-01-012021-06-30" decimals="INF" unitRef="Shares"> -0.03 </mdxl:BasicAndDilutedLps>
<us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock contextRef="From2022-01-01to2022-06-30">
<table cellpadding="0" cellspacing="0" id="xdx_892_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_z3YbpoqGo02i" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of Significant Accounting Policies (Schedule of potentially dilutive securities) (Details)"> <tr style="vertical-align: bottom; background-color: transparent"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_8B3_zflT2rFWMpdg" style="display: none">Schedule of potentially dilutive securities not included in the calculation of diluted net loss per share</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 48%; text-align: left">Series A Preferred stock (convertible)</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_98D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220401__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_z2FQtpEWdnDh" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Anti-dilutive securities">24,900,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_988_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210401__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zYESRxtUe19b" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Anti-dilutive securities">24,900,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_983_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_pdd" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Anti-dilutive securities">24,900,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_98D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_pdd" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Anti-dilutive securities">24,900,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: transparent"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Series B Preferred stock (convertible)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220401__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zEGOiQ3z6HY8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Anti-dilutive securities">15,637,490</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_982_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210401__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zGlhEWCNNRqe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Anti-dilutive securities">11,937,440</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_980_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Anti-dilutive securities">15,637,440</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_982_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Anti-dilutive securities">11,937,440</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Senior Convertible Debentures and Warrants</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_980_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220401__20220630__us-gaap--StatementClassOfStockAxis__custom--SeniorConvertibleDebenturesAndWarrantsMember_zXwaJRX1Nt3g" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Anti-dilutive securities">1,233,625</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_980_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d0_c20210401__20210630__us-gaap--StatementClassOfStockAxis__custom--SeniorConvertibleDebenturesAndWarrantsMember_zW0cu8KNjNq4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Anti-dilutive securities">—</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20220630__us-gaap--StatementClassOfStockAxis__custom--SeniorConvertibleDebenturesAndWarrantsMember_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Anti-dilutive securities">1,616,125</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d0_c20210101__20210630__us-gaap--StatementClassOfStockAxis__custom--SeniorConvertibleDebenturesAndWarrantsMember_zjMcn1N5ur11" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Anti-dilutive securities">—</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> </table>
</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
<us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="From2022-04-012022-06-30_us-gaap_SeriesAPreferredStockMember" decimals="INF" unitRef="Shares"> 24900000 </us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
<us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="From2021-04-012021-06-30_us-gaap_SeriesAPreferredStockMember" decimals="INF" unitRef="Shares"> 24900000 </us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
<us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="From2022-01-012022-06-30_us-gaap_SeriesAPreferredStockMember" decimals="INF" unitRef="Shares"> 24900000 </us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
<us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="From2021-01-012021-06-30_us-gaap_SeriesAPreferredStockMember" decimals="INF" unitRef="Shares"> 24900000 </us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
<us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="From2022-04-012022-06-30_us-gaap_SeriesBPreferredStockMember" decimals="INF" unitRef="Shares"> 15637490 </us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
<us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="From2021-04-012021-06-30_us-gaap_SeriesBPreferredStockMember" decimals="INF" unitRef="Shares"> 11937440 </us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
<us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="From2022-01-012022-06-30_us-gaap_SeriesBPreferredStockMember" decimals="INF" unitRef="Shares"> 15637440 </us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
<us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="From2021-01-012021-06-30_us-gaap_SeriesBPreferredStockMember" decimals="INF" unitRef="Shares"> 11937440 </us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
<us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="From2022-04-012022-06-30_custom_SeniorConvertibleDebenturesAndWarrantsMember" decimals="INF" unitRef="Shares"> 1233625 </us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
<us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="From2021-04-012021-06-30_custom_SeniorConvertibleDebenturesAndWarrantsMember" decimals="INF" unitRef="Shares"> 0 </us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
<us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="From2022-01-012022-06-30_custom_SeniorConvertibleDebenturesAndWarrantsMember" decimals="INF" unitRef="Shares"> 1616125 </us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
<us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="From2021-01-012021-06-30_custom_SeniorConvertibleDebenturesAndWarrantsMember" decimals="INF" unitRef="Shares"> 0 </us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
<us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock contextRef="From2022-01-01to2022-06-30">
<p id="xdx_84F_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zHQ9zSmfb9P7" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span id="xdx_86B_zQsy0JqsZtPd">Recoverability of Long-Lived Assets</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc">The Company assesses the recoverability of long-lived assets annually or whenever events or changes in circumstances indicate that expected future undiscounted cash flows might not be sufficient to support the carrying amount of an asset. The Company deems an asset to be impaired if a forecast of undiscounted future operating cash flows is less than the carrying amount. If an asset is determined to be impaired, the loss is measured as the amount by which the carrying value of the asset exceeds its fair value. There was <span id="xdx_90C_eus-gaap--ImpairmentOfLongLivedAssetsHeldForUse_do_c20220401__20220630_zhxRMMS1tfzf" title="Impairment of long-lived assets"><span id="xdx_900_eus-gaap--ImpairmentOfLongLivedAssetsHeldForUse_do_c20220101__20220630_zTqvP58OGsrk" title="Impairment of long-lived assets"><span id="xdx_904_eus-gaap--ImpairmentOfLongLivedAssetsHeldForUse_do_c20210401__20210630_zwNrC3wwQ9Si" title="Impairment of long-lived assets"><span id="xdx_90E_eus-gaap--ImpairmentOfLongLivedAssetsHeldForUse_do_c20210101__20210630_zQ7Nc68N5Ifj" title="Impairment of long-lived assets">no</span></span></span></span> impairment of long-lived assets pertaining to the three and six months periods ended June 30, 2022 and 2021. However, there can be no assurances that future impairment tests will not result in a charge to operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">   </p>
</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
<us-gaap:ImpairmentOfLongLivedAssetsHeldForUse contextRef="From2022-04-012022-06-30" decimals="0" unitRef="USD"> 0 </us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
<us-gaap:ImpairmentOfLongLivedAssetsHeldForUse contextRef="From2022-01-01to2022-06-30" decimals="0" unitRef="USD"> 0 </us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
<us-gaap:ImpairmentOfLongLivedAssetsHeldForUse contextRef="From2021-04-012021-06-30" decimals="0" unitRef="USD"> 0 </us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
<us-gaap:ImpairmentOfLongLivedAssetsHeldForUse contextRef="From2021-01-012021-06-30" decimals="0" unitRef="USD"> 0 </us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
<mdxl:RightsToUseIntellectualPropertyPolicyTextBlock contextRef="From2022-01-01to2022-06-30">
<p id="xdx_844_ecustom--RightsToUseIntellectualPropertyPolicyTextBlock_zlfHSkDDLOSh" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span id="xdx_86C_zFSxSVulZbN2">Rights-to-use Intellectual Property</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The rights-to-use intellectual property (“Intellectual Property”) is an intangible asset arising from the Company’s right to use the proprietary technology and programs of the Virtual Clinic. The Intellectual Property was initially measured at fair value and will be amortized on a straightline basis over its estimated useful life as the economic benefits are consumed or otherwise realized. Management has determined the estimated useful life to be seven years.</p>
</mdxl:RightsToUseIntellectualPropertyPolicyTextBlock>
<us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock contextRef="From2022-01-01to2022-06-30">
<p id="xdx_84A_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_zwdH0vBS2lgc" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span id="xdx_869_zj2E5eMy8cH6">Website and Development Costs</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc">Internal and external costs incurred to develop, the internal-use computer software during the application and development stage shall be capitalized subsequent to the preliminary project stage and when it is probable that the project will be completed. As of June 30, 2022 and December 31, 2021, the Company has met the capitalization requirements and has incurred $<span id="xdx_903_eus-gaap--CapitalizedComputerSoftwareNet_iI_pp0p0_c20220630_zrZVj9t0YLqh" title="Website and development costs"><span id="xdx_903_eus-gaap--CapitalizedComputerSoftwareNet_iI_pp0p0_c20211231_z5GYeekGFI8k" title="Website and development costs">451,404</span></span> at both periods, in costs related to the development of the MediXall platform. Upon completion, the related assets will be amortized over the estimated useful life of the underlying product. The Company will amortize the cost of the intangible asset using amortization methods that reflect the pattern in which the economic benefits of the intangible asset are consumed or otherwise realized.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b> </b></p>
</us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock>
<us-gaap:CapitalizedComputerSoftwareNet contextRef="AsOf2022-06-30" decimals="0" unitRef="USD"> 451404 </us-gaap:CapitalizedComputerSoftwareNet>
<us-gaap:CapitalizedComputerSoftwareNet contextRef="AsOf2021-12-31" decimals="0" unitRef="USD"> 451404 </us-gaap:CapitalizedComputerSoftwareNet>
<us-gaap:ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy contextRef="From2022-01-01to2022-06-30">
<p id="xdx_845_eus-gaap--ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_zsVaitI9I69l" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_868_zB4DhTsYTKU2">Allowance for Uncollectible Accounts Receivable</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc">An allowance for uncollectible accounts receivable is recorded when management believes the uncollectability of the accounts receivable is confirmed. Subsequent recoveries, if any, are credited to the allowance. The allowance is determined based on management’s review of the debtor’s ability to repay and repayment history, aging history, and estimated value of collateral, if any.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc"> </p>
</us-gaap:ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy>
<us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2022-01-01to2022-06-30">
<p id="xdx_842_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_znaB1SMDhIyc" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span id="xdx_86E_z1eXj39kUwP4">Recent Accounting Pronouncements</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 3pc">Management does not believe that any recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company’s consolidated financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc"> <b> </b></p>
</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
<us-gaap:IntangibleAssetsDisclosureTextBlock contextRef="From2022-01-01to2022-06-30">
<p id="xdx_808_eus-gaap--IntangibleAssetsDisclosureTextBlock_zDzPFy6F38g5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span style="text-decoration: underline">NOTE 5 - <span id="xdx_829_z8xK6jePvfs7">Right-to-use Intellectual Property</span> </span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 3pc">Right-to-use Intellectual Property consists of the following:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_897_ecustom--ScheduleOfRightToUseIntellectualPropertyTableTextBlock_z6ZMTc8mUume" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Right-to-use Intellectual Property (Schedule of Right-to-use Intellectual Property) (Details)"> <tr style="vertical-align: bottom"> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: center"><span style="font-size: 10pt"><span id="xdx_8BF_zbmzEaEPcyf6" style="display: none">Schedule of Right-to-use Intellectual Property </span></span></td><td style="font: 11pt Calibri, Helvetica, Sans-Serif"> </td> <td colspan="2" style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: center"> </td><td style="font: 11pt Calibri, Helvetica, Sans-Serif"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="font: 10pt Times New Roman, Times, Serif; text-decoration: underline">Balances, June 30, 2022</td><td style="font: 11pt Calibri, Helvetica, Sans-Serif"> </td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left"> </td><td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: right"> </td><td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: transparent"> <td style="font: 10pt Times New Roman, Times, Serif; width: 87%">Gross</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$ </td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630_pp0p0" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Gross">236,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Accumulated amortization</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_pp0p0_di_c20220630_zR52Kaez26m2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Accumulated amortization">(16,858</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: transparent"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Net carrying amount</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsNet_c20220630_pp0p0" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Net carrying amount">219,142</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A2_zf01YGkyULaf" style="font: 12pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 3pc; text-align: justify">Estimated amortization expense for the right-to-use intellectual property for each of the future years ending December 31, is as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_894_ecustom--ScheduleOfAmortizationExpenseForTheRightToUseIntellectualPropertyTableTextBlock_zsODNqlEaP6a" style="width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Right-to-use Intellectual Property (Schedule of amortization expense for right-to-use intellectual property) (Details)"> <tr style="background-color: white"> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: top"><span id="xdx_8B0_z0CfRDgEtByf" style="display: none">Schedule of amortization expense for right-to-use intellectual property</span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom"> </td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom"> </td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom"> </td> <td id="xdx_490_20220630_zkpRcbYb4U9f" style="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"> </td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom"> </td></tr> <tr id="xdx_40B_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths_iI_pp0p0_maFLIANzamD_zsVWDRdHY1W9" style="background-color: #CCFFCC"> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: top; width: 86%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022 (six months)</span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom; width: 1%"> </td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom; width: 1%"> </td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16,857</span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom; width: 1%"> </td></tr> <tr id="xdx_40A_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo_iI_pp0p0_maFLIANzamD_ziQ6dBEJzTu4" style="background-color: white"> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom"> </td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom"> </td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom"> </td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33,714</span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom"> </td></tr> <tr id="xdx_40A_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree_iI_pp0p0_maFLIANzamD_zBQcAt3puyJ1" style="background-color: #CCFFCC"> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom"> </td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom"> </td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom"> </td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33,714</span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom"> </td></tr> <tr id="xdx_40C_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour_iI_pp0p0_maFLIANzamD_zcH99ysHZ8Lb" style="background-color: white"> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom"> </td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom"> </td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom"> </td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33,714</span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom"> </td></tr> <tr id="xdx_40E_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFive_iI_pp0p0_maFLIANzamD_zIwN8MEzNqX8" style="background-color: #CCFFCC"> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2026</span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom"> </td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom"> </td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom"> </td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33,714</span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom"> </td></tr> <tr id="xdx_40C_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseRollingAfterYearFive_iI_pp0p0_maFLIANzamD_zl49TgQbOyne" style="background-color: white"> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thereafter</span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom"> </td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom"> </td> <td style="border-bottom: black 1pt solid; font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom"> </td> <td style="border-bottom: black 1pt solid; font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">67,429</span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom"> </td></tr> <tr id="xdx_402_eus-gaap--FiniteLivedIntangibleAssetsNet_iTI_pp0p0_mtFLIANzamD_z2e2JJ1X3s3d" style="background-color: #CCFFCC"> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom"> </td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom"> </td> <td style="border-bottom: black 2.25pt double; font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="border-bottom: black 2.25pt double; font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">219,142</span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom"> </td></tr> </table> <p id="xdx_8A5_zmtPKYJxz5W7" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>  </b></p>
</us-gaap:IntangibleAssetsDisclosureTextBlock>
<mdxl:ScheduleOfRightToUseIntellectualPropertyTableTextBlock contextRef="From2022-01-01to2022-06-30">
<table cellpadding="0" cellspacing="0" id="xdx_897_ecustom--ScheduleOfRightToUseIntellectualPropertyTableTextBlock_z6ZMTc8mUume" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Right-to-use Intellectual Property (Schedule of Right-to-use Intellectual Property) (Details)"> <tr style="vertical-align: bottom"> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: center"><span style="font-size: 10pt"><span id="xdx_8BF_zbmzEaEPcyf6" style="display: none">Schedule of Right-to-use Intellectual Property </span></span></td><td style="font: 11pt Calibri, Helvetica, Sans-Serif"> </td> <td colspan="2" style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: center"> </td><td style="font: 11pt Calibri, Helvetica, Sans-Serif"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="font: 10pt Times New Roman, Times, Serif; text-decoration: underline">Balances, June 30, 2022</td><td style="font: 11pt Calibri, Helvetica, Sans-Serif"> </td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left"> </td><td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: right"> </td><td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: transparent"> <td style="font: 10pt Times New Roman, Times, Serif; width: 87%">Gross</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$ </td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630_pp0p0" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Gross">236,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Accumulated amortization</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_pp0p0_di_c20220630_zR52Kaez26m2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Accumulated amortization">(16,858</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: transparent"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Net carrying amount</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsNet_c20220630_pp0p0" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Net carrying amount">219,142</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>
</mdxl:ScheduleOfRightToUseIntellectualPropertyTableTextBlock>
<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="AsOf2022-06-30" decimals="0" unitRef="USD"> 236000 </us-gaap:FiniteLivedIntangibleAssetsGross>
<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="AsOf2022-06-30" decimals="0" unitRef="USD"> 16858 </us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
<us-gaap:FiniteLivedIntangibleAssetsNet contextRef="AsOf2022-06-30" decimals="0" unitRef="USD"> 219142 </us-gaap:FiniteLivedIntangibleAssetsNet>
<mdxl:ScheduleOfAmortizationExpenseForTheRightToUseIntellectualPropertyTableTextBlock contextRef="From2022-01-01to2022-06-30">
<table cellpadding="0" cellspacing="0" id="xdx_894_ecustom--ScheduleOfAmortizationExpenseForTheRightToUseIntellectualPropertyTableTextBlock_zsODNqlEaP6a" style="width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Right-to-use Intellectual Property (Schedule of amortization expense for right-to-use intellectual property) (Details)"> <tr style="background-color: white"> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: top"><span id="xdx_8B0_z0CfRDgEtByf" style="display: none">Schedule of amortization expense for right-to-use intellectual property</span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom"> </td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom"> </td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom"> </td> <td id="xdx_490_20220630_zkpRcbYb4U9f" style="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"> </td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom"> </td></tr> <tr id="xdx_40B_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths_iI_pp0p0_maFLIANzamD_zsVWDRdHY1W9" style="background-color: #CCFFCC"> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: top; width: 86%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022 (six months)</span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom; width: 1%"> </td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom; width: 1%"> </td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16,857</span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom; width: 1%"> </td></tr> <tr id="xdx_40A_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo_iI_pp0p0_maFLIANzamD_ziQ6dBEJzTu4" style="background-color: white"> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom"> </td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom"> </td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom"> </td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33,714</span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom"> </td></tr> <tr id="xdx_40A_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree_iI_pp0p0_maFLIANzamD_zBQcAt3puyJ1" style="background-color: #CCFFCC"> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom"> </td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom"> </td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom"> </td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33,714</span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom"> </td></tr> <tr id="xdx_40C_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour_iI_pp0p0_maFLIANzamD_zcH99ysHZ8Lb" style="background-color: white"> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom"> </td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom"> </td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom"> </td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33,714</span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom"> </td></tr> <tr id="xdx_40E_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFive_iI_pp0p0_maFLIANzamD_zIwN8MEzNqX8" style="background-color: #CCFFCC"> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2026</span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom"> </td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom"> </td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom"> </td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33,714</span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom"> </td></tr> <tr id="xdx_40C_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseRollingAfterYearFive_iI_pp0p0_maFLIANzamD_zl49TgQbOyne" style="background-color: white"> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thereafter</span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom"> </td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom"> </td> <td style="border-bottom: black 1pt solid; font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom"> </td> <td style="border-bottom: black 1pt solid; font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">67,429</span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom"> </td></tr> <tr id="xdx_402_eus-gaap--FiniteLivedIntangibleAssetsNet_iTI_pp0p0_mtFLIANzamD_z2e2JJ1X3s3d" style="background-color: #CCFFCC"> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom"> </td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom"> </td> <td style="border-bottom: black 2.25pt double; font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="border-bottom: black 2.25pt double; font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">219,142</span></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom"> </td></tr> </table>
</mdxl:ScheduleOfAmortizationExpenseForTheRightToUseIntellectualPropertyTableTextBlock>
<us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths contextRef="AsOf2022-06-30" decimals="0" unitRef="USD"> 16857 </us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths>
<us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo contextRef="AsOf2022-06-30" decimals="0" unitRef="USD"> 33714 </us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo>
<us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree contextRef="AsOf2022-06-30" decimals="0" unitRef="USD"> 33714 </us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree>
<us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour contextRef="AsOf2022-06-30" decimals="0" unitRef="USD"> 33714 </us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour>
<us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFive contextRef="AsOf2022-06-30" decimals="0" unitRef="USD"> 33714 </us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFive>
<us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRollingAfterYearFive contextRef="AsOf2022-06-30" decimals="0" unitRef="USD"> 67429 </us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRollingAfterYearFive>
<us-gaap:FiniteLivedIntangibleAssetsNet contextRef="AsOf2022-06-30" decimals="0" unitRef="USD"> 219142 </us-gaap:FiniteLivedIntangibleAssetsNet>
<us-gaap:PreferredStockTextBlock contextRef="From2022-01-01to2022-06-30">
<p id="xdx_808_eus-gaap--PreferredStockTextBlock_z5shLNnJoAx4" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><span style="text-decoration: underline">Note 6 – <span id="xdx_824_zV1Fjz189I5c">Preferred Stock</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt/11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc">The <span id="xdx_90A_eus-gaap--PreferredStockSharesOutstanding_iI_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zcvlz2073b1l" title="Convertible Preferred stock, shares outstanding">264,894</span> outstanding Series A preferred shares are convertible into <span id="xdx_90A_ecustom--ConvertiblePreferredStockTotalSharesIssuedUponConversion_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_pdd" title="Number of common stock issuable for total shares of convertible preferred stock">24,900,000</span> common shares. The preferred shares do not pay dividends. The number of votes for the preferred shares shall be the same as the amount of shares of common shares that would be issued upon conversion.</p> <p style="font: 10pt/11pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc">On June 24, 2020, the Company filed with the Secretary of State of the State of Nevada (the “Secretary of State”) a certificate of designation (the “Certificate of Designation”) of <i>Series B Convertible Preferred Stock</i>, par value $<span id="xdx_90E_eus-gaap--PreferredStockParOrStatedValuePerShare_c20200624__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_pdd" title="Convertible Preferred stock, par value">0.001</span> per share (the “Series B Preferred Stock”). The Certificate of Designation was effective upon filing with the Secretary of State and designated a new series of preferred stock of the Company as Series B Convertible Preferred Stock with <span id="xdx_90F_eus-gaap--PreferredStockSharesAuthorized_c20200624__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_pdd" title="Convertible Preferred stock, shares authorized">4,000,000</span> shares authorized for issuance.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 3pc"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc">Upon the occurrence of the events as set forth in paragraph (a) or (b) below, each share of Series B Preferred Stock shall be converted into four (the “Conversion Ratio”) fully paid and non-assessable shares of common stock or any shares of capital stock or other securities of the Company into which such common stock shall hereafter be changed or reclassified (the “Conversion Shares”) as set forth in the Certificate of Designation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 3pc"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i>(a)       <span style="text-decoration: underline">Automatic Conversion</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc">Immediately upon the listing of the common stock for trading on the New York Stock Exchange or the Nasdaq Stock Market, all of the issued and outstanding shares of Series B Preferred Stock shall automatically be converted into Conversion Shares without any further action of any holder of Series B Preferred Stock (each, a “Series B Holder” and collectively, “Series B Holders”).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i>(b)       <span style="text-decoration: underline">Optional Conversion</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 3pc"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc">A Series B Holder shall have the right at any time during the period beginning on the date which is six months following the date that the Series B Preferred Stock is initially issued and prior to any automatic conversion as provided in the Certificate of Designation, to convert all or any part of the outstanding Series B Preferred Stock held by such Series B Holder into Conversion Shares at the Conversion Ratio as provided in the Certificate of Designation, subject to limitations set forth in the Certificate of Designation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 3pc"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="background-color: white"><i><span style="text-decoration: underline">Dividends</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc"><span style="background-color: white">Series B Holders will be entitled to receive a quarterly dividend, until the conversion of the Series B Preferred Stock, at the rate of <span id="xdx_90C_eus-gaap--PreferredStockDividendRatePercentage_dp_c20220101__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zV9OKCVvU8e7" title="Dividend rate">8</span>% per annum (the “Series B Dividend”). The Series B Dividend will be cumulative, shall accrue quarterly, and be paid via the issuance of a number of shares of common stock of the Company equal to (1) the dollar amount of the Series B Dividend being paid, divided by (2) $<span id="xdx_90B_eus-gaap--PreferredStockDividendRatePerDollarAmount_c20220101__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_pdd" title="Stock dividend">0.25</span> (the “Stock Dividend”). The Stock Dividend shall be paid via the issuance to the applicable Series B Holder of the applicable shares of common stock via book entry in the books and records of the Company. At June 30, 2022, cumulative unpaid dividends on the Series B Preferred Stock amounted to $<span id="xdx_90F_eus-gaap--DividendsPayableCurrent_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_pp0p0" title="Cummulative unpaid dividends">435,361</span>. <span id="xdx_903_eus-gaap--CommonStockDividendsShares_do_c20220101__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zTuG4OGZ5Nyb" title="Common stock issued in satisfaction of preferred stock dividend">No</span> common stock has been issued as of June 30, 2022 in satisfaction of the preferred stock dividend.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="background-color: white"><i><span style="text-decoration: underline">Voting Rights</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc">Each share of Series B Preferred Stock shall have a number of votes on any matter submitted to the holders of the Company’s common stock, or any class thereof, for a vote, equal to the number of Conversion Shares into which the Series B Preferred Stock is then convertible, and shall vote together with the common stock, or any class thereof, as applicable, as one class on such matter for as long as the share of Series B Preferred Stock is issued and outstanding.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b> </b></p>
</us-gaap:PreferredStockTextBlock>
<us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2022-06-30_us-gaap_SeriesAPreferredStockMember" decimals="INF" unitRef="Shares"> 264894 </us-gaap:PreferredStockSharesOutstanding>
<mdxl:ConvertiblePreferredStockTotalSharesIssuedUponConversion contextRef="AsOf2022-06-30_us-gaap_SeriesAPreferredStockMember" decimals="INF" unitRef="Shares"> 24900000 </mdxl:ConvertiblePreferredStockTotalSharesIssuedUponConversion>
<us-gaap:PreferredStockParOrStatedValuePerShare contextRef="AsOf2020-06-24_us-gaap_SeriesBPreferredStockMember" decimals="INF" unitRef="USDPShares"> 0.001 </us-gaap:PreferredStockParOrStatedValuePerShare>
<us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2020-06-24_us-gaap_SeriesBPreferredStockMember" decimals="INF" unitRef="Shares"> 4000000 </us-gaap:PreferredStockSharesAuthorized>
<us-gaap:PreferredStockDividendRatePercentage contextRef="From2022-01-012022-06-30_us-gaap_SeriesBPreferredStockMember" decimals="INF" unitRef="Pure"> 0.08 </us-gaap:PreferredStockDividendRatePercentage>
<us-gaap:PreferredStockDividendRatePerDollarAmount contextRef="From2022-01-012022-06-30_us-gaap_SeriesBPreferredStockMember" decimals="INF" unitRef="USDPShares"> 0.25 </us-gaap:PreferredStockDividendRatePerDollarAmount>
<us-gaap:DividendsPayableCurrent contextRef="AsOf2022-06-30_us-gaap_SeriesBPreferredStockMember" decimals="0" unitRef="USD"> 435361 </us-gaap:DividendsPayableCurrent>
<us-gaap:CommonStockDividendsShares contextRef="From2022-01-012022-06-30_us-gaap_SeriesBPreferredStockMember" decimals="INF" unitRef="Shares"> 0 </us-gaap:CommonStockDividendsShares>
<us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2022-01-01to2022-06-30">
<p id="xdx_80B_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_z0nnpqPraZHc" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><span style="text-decoration: underline">Note 7 – <span id="xdx_82F_zE1r9AyTKgl5">Related Party Transactions</span> </span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc">Pursuant to an agreement dated June 2013 and amended in July 2021, TBG Holdings Corp. (“TBG”), was engaged to provide business advisory services, manage and direct our public relations, provide recruiting services, develop and maintain material for market makers and investment bankers, provide general administrative services, and respond to incoming investor relations calls. TBG is owned in part by Neil Swartz, the Company’s Interim Chief Executive Officer and director, and a significant stockholder of the Company, and Timothy Hart, the Company’s Chief Financial Officer and director, and a significant stockholder of the Company. Effective on June 14, 2022, Neil Swartz voluntarily resigned as CEO at MediXall Group, Inc. and the Company appointed Noel J. Guillama-Alvarez as his successor. Under this agreement, we pay TBG a monthly fee of $<span id="xdx_903_eus-gaap--RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_c20220101__20220630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TBGMember_pp0p0" title="Fee for consulting and administrative services">40,000</span>. In April 2021, we entered into an additional agreement with TBG to provide management services specifically to our Health Karma subsidiary. Under this new agreement, we pay TBG an additional monthly fee of $<span id="xdx_904_eus-gaap--DebtInstrumentPeriodicPayment_c20210401__20210430_pp0p0" title="Debt Instrument, Periodic Payment">40,000</span>. During the three months ended June 30, 2022 and 2021, the Company expensed $<span id="xdx_901_eus-gaap--ManagementFeeExpense_c20220101__20220630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TBGMember_pp0p0" title="Management fee - related party"><span id="xdx_903_eus-gaap--ManagementFeeExpense_c20210101__20210630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TBGMember_pp0p0" title="Management fee - related party">240,000</span></span> for both periods for related party management fees related to these agreements. <span style="background-color: white">During the six months ended June 30, 2022 and 2021, the Company expensed $<span id="xdx_90C_eus-gaap--OtherPrepaidExpenseCurrent_c20220630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TBGMember_pp0p0" title="Prepaid expenses- related party">480,000</span> and $<span id="xdx_90B_eus-gaap--OtherPrepaidExpenseCurrent_iI_pp0p0_c20210630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TBGMember_zVuOhEojjoka" title="Prepaid expenses- related party">360,000</span>, respectively, of related party management fees related to these agreements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc"><span style="background-color: white">During the three and six month period ended June 30, 2021, the Company paid $<span id="xdx_907_eus-gaap--MarketingExpense_pp0p0_c20210401__20210630_zlXTtQdGIvA7" title="Marketing and Consulting expenses">181,500</span> and $<span id="xdx_90E_eus-gaap--MarketingExpense_c20210101__20210630_pp0p0" title="Marketing and Consulting expenses">275,500</span> in marketing and consulting expenses to two companies which are owned by the president of Turnkey a related party. There was no such fee during the three and six month period ended June 30, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc"> <span style="background-color: white">R3 Accounting LLC (“R3”), owned by Mr. Hart, provides accounting, tax and bookkeeping services to the Company. During the three and six months ended June 30, 2022 and 2021, the Company expensed  $<span id="xdx_909_eus-gaap--RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_pp0p0_c20220401__20220630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--R3AccountingLLCMember_zjVasjcDC4T8" title="Fee for consulting and administrative services">57,500</span> and $<span id="xdx_901_eus-gaap--RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_c20220101__20220630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--R3AccountingLLCMember_pp0p0" title="Fee for consulting and administrative services">65,500</span> and $<span id="xdx_903_eus-gaap--RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_pp0p0_c20210401__20210630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--R3AccountingLLCMember_zqRpKSOvK95a" title="Fee for consulting and administrative services">177,500</span> and $<span id="xdx_903_eus-gaap--RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_c20210101__20210630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--R3AccountingLLCMember_pp0p0" title="Fee for consulting and administrative services">135,538</span>, respectively, related to R3 services.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc">The Company received short term cash advances during 2021 from Turnkey. The advances are due on demand, unsecured, and do not bear any interest.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 3pc">Prepaid expenses (accounts payable and accrued expenses) to related parties are as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_885_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_za2O5ZnRmGK3" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Related Party Transactions (Details)"> <tr style="vertical-align: bottom"> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span id="xdx_8B7_zkugscxwHWe8" style="display: none">Schedule of prepaid expenses (accounts payable and accrued expenses) to related parties</span></td><td style="font: 11pt Calibri, Helvetica, Sans-Serif"> </td> <td colspan="2" style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: right"> </td><td style="font: 11pt Calibri, Helvetica, Sans-Serif"> </td><td style="font: 11pt Calibri, Helvetica, Sans-Serif"> </td> <td colspan="2" style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: right"> </td><td style="font: 11pt Calibri, Helvetica, Sans-Serif"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif">Related Party</td><td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>At</b></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>June 30,</b></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>2022</b></p></td><td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td><td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>At</b></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>December 31,</b></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>2021</b></p></td><td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 74%">TBG</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--AccountsPayableRelatedPartiesCurrent_iNI_pp0p0_di_c20220630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TBGHoldingsCorpMember_zk2rdE3DLdO2" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Accounts payable and accrued expenses - related party">(17,415</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--PrepaidExpenseCurrent_iI_pp0p0_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TBGHoldingsCorpMember_zwCqSajmlEgb" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Prepaid expense">276,043</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: transparent"> <td style="font: 10pt Times New Roman, Times, Serif">Turnkey</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98F_eus-gaap--AccountsPayableRelatedPartiesCurrent_iNI_pp0p0_di_c20220630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TurnkeyMember_z0Af7RK0qpn6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Accounts payable and accrued expenses - related party">(547,650</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98F_eus-gaap--AccountsPayableRelatedPartiesCurrent_iNI_pp0p0_di_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TurnkeyMember_zAaM3K6nRDWe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Accounts payable and accrued expenses - related party">(549,150</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">R3</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98E_eus-gaap--AccountsPayableRelatedPartiesCurrent_iNI_pp0p0_di_c20220630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--R3AccountingLLCMember_zV0lslEPQYLd" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Accounts payable and accrued expenses - related party">(92,172</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_983_eus-gaap--AccountsPayableRelatedPartiesCurrent_iNI_pp0p0_di_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--R3AccountingLLCMember_zU7E0r8zSTn9" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Accounts payable and accrued expenses - related party">(18,052</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: transparent"> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; padding-bottom: 2.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_986_eus-gaap--RelatedPartyTransactionDueFromToRelatedParty_iNI_pp0p0_di_c20220630_zJTKBUhB50I4" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Due from (to) related party">(657,237</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_989_eus-gaap--RelatedPartyTransactionDueFromToRelatedParty_iNI_pp0p0_di_c20211231_zSSKKv7uwMcb" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Due from (to) related party">(291,159</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">  </p>
</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
<us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty contextRef="From2022-01-012022-06-30_custom_TBGMember" decimals="0" unitRef="USD"> 40000 </us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
<us-gaap:DebtInstrumentPeriodicPayment contextRef="From2021-04-012021-04-30" decimals="0" unitRef="USD"> 40000 </us-gaap:DebtInstrumentPeriodicPayment>
<us-gaap:ManagementFeeExpense contextRef="From2022-01-012022-06-30_custom_TBGMember" decimals="0" unitRef="USD"> 240000 </us-gaap:ManagementFeeExpense>
<us-gaap:ManagementFeeExpense contextRef="From2021-01-012021-06-30_custom_TBGMember" decimals="0" unitRef="USD"> 240000 </us-gaap:ManagementFeeExpense>
<us-gaap:OtherPrepaidExpenseCurrent contextRef="AsOf2022-06-30_custom_TBGMember" decimals="0" unitRef="USD"> 480000 </us-gaap:OtherPrepaidExpenseCurrent>
<us-gaap:OtherPrepaidExpenseCurrent contextRef="AsOf2021-06-30_custom_TBGMember" decimals="0" unitRef="USD"> 360000 </us-gaap:OtherPrepaidExpenseCurrent>
<us-gaap:MarketingExpense contextRef="From2021-04-012021-06-30" decimals="0" unitRef="USD"> 181500 </us-gaap:MarketingExpense>
<us-gaap:MarketingExpense contextRef="From2021-01-012021-06-30" decimals="0" unitRef="USD"> 275500 </us-gaap:MarketingExpense>
<us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty contextRef="From2022-04-012022-06-30_custom_R3AccountingLLCMember" decimals="0" unitRef="USD"> 57500 </us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
<us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty contextRef="From2022-01-012022-06-30_custom_R3AccountingLLCMember" decimals="0" unitRef="USD"> 65500 </us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
<us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty contextRef="From2021-04-012021-06-30_custom_R3AccountingLLCMember" decimals="0" unitRef="USD"> 177500 </us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
<us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty contextRef="From2021-01-012021-06-30_custom_R3AccountingLLCMember" decimals="0" unitRef="USD"> 135538 </us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
<us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock contextRef="From2022-01-01to2022-06-30">
<table cellpadding="0" cellspacing="0" id="xdx_885_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_za2O5ZnRmGK3" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Related Party Transactions (Details)"> <tr style="vertical-align: bottom"> <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span id="xdx_8B7_zkugscxwHWe8" style="display: none">Schedule of prepaid expenses (accounts payable and accrued expenses) to related parties</span></td><td style="font: 11pt Calibri, Helvetica, Sans-Serif"> </td> <td colspan="2" style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: right"> </td><td style="font: 11pt Calibri, Helvetica, Sans-Serif"> </td><td style="font: 11pt Calibri, Helvetica, Sans-Serif"> </td> <td colspan="2" style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: right"> </td><td style="font: 11pt Calibri, Helvetica, Sans-Serif"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif">Related Party</td><td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>At</b></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>June 30,</b></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>2022</b></p></td><td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td><td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>At</b></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>December 31,</b></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>2021</b></p></td><td style="font: 8pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 74%">TBG</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--AccountsPayableRelatedPartiesCurrent_iNI_pp0p0_di_c20220630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TBGHoldingsCorpMember_zk2rdE3DLdO2" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Accounts payable and accrued expenses - related party">(17,415</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--PrepaidExpenseCurrent_iI_pp0p0_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TBGHoldingsCorpMember_zwCqSajmlEgb" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Prepaid expense">276,043</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: transparent"> <td style="font: 10pt Times New Roman, Times, Serif">Turnkey</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98F_eus-gaap--AccountsPayableRelatedPartiesCurrent_iNI_pp0p0_di_c20220630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TurnkeyMember_z0Af7RK0qpn6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Accounts payable and accrued expenses - related party">(547,650</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98F_eus-gaap--AccountsPayableRelatedPartiesCurrent_iNI_pp0p0_di_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TurnkeyMember_zAaM3K6nRDWe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Accounts payable and accrued expenses - related party">(549,150</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,255,204)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">R3</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98E_eus-gaap--AccountsPayableRelatedPartiesCurrent_iNI_pp0p0_di_c20220630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--R3AccountingLLCMember_zV0lslEPQYLd" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Accounts payable and accrued expenses - related party">(92,172</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_983_eus-gaap--AccountsPayableRelatedPartiesCurrent_iNI_pp0p0_di_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--R3AccountingLLCMember_zU7E0r8zSTn9" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Accounts payable and accrued expenses - related party">(18,052</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: transparent"> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; padding-bottom: 2.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_986_eus-gaap--RelatedPartyTransactionDueFromToRelatedParty_iNI_pp0p0_di_c20220630_zJTKBUhB50I4" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Due from (to) related party">(657,237</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_989_eus-gaap--RelatedPartyTransactionDueFromToRelatedParty_iNI_pp0p0_di_c20211231_zSSKKv7uwMcb" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Due from (to) related party">(291,159</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td></tr> </table>
</us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
<us-gaap:AccountsPayableRelatedPartiesCurrent contextRef="AsOf2022-06-30_custom_TBGHoldingsCorpMember" decimals="0" unitRef="USD"> 17415 </us-gaap:AccountsPayableRelatedPartiesCurrent>
<us-gaap:PrepaidExpenseCurrent contextRef="AsOf2021-12-31_custom_TBGHoldingsCorpMember" decimals="0" unitRef="USD"> 276043 </us-gaap:PrepaidExpenseCurrent>
<us-gaap:AccountsPayableRelatedPartiesCurrent contextRef="AsOf2022-06-30_custom_TurnkeyMember" decimals="0" unitRef="USD"> 547650 </us-gaap:AccountsPayableRelatedPartiesCurrent>
<us-gaap:AccountsPayableRelatedPartiesCurrent contextRef="AsOf2021-12-31_custom_TurnkeyMember" decimals="0" unitRef="USD"> 549150 </us-gaap:AccountsPayableRelatedPartiesCurrent>
<us-gaap:AccountsPayableRelatedPartiesCurrent contextRef="AsOf2022-06-30_custom_R3AccountingLLCMember" decimals="0" unitRef="USD"> 92172 </us-gaap:AccountsPayableRelatedPartiesCurrent>
<us-gaap:AccountsPayableRelatedPartiesCurrent contextRef="AsOf2021-12-31_custom_R3AccountingLLCMember" decimals="0" unitRef="USD"> 18052 </us-gaap:AccountsPayableRelatedPartiesCurrent>
<us-gaap:RelatedPartyTransactionDueFromToRelatedParty contextRef="AsOf2022-06-30" decimals="0" unitRef="USD"> 657237 </us-gaap:RelatedPartyTransactionDueFromToRelatedParty>
<us-gaap:RelatedPartyTransactionDueFromToRelatedParty contextRef="AsOf2021-12-31" decimals="0" unitRef="USD"> 291159 </us-gaap:RelatedPartyTransactionDueFromToRelatedParty>
<mdxl:SeniorConvertibleDebenturesAndWarrantsTextBlock contextRef="From2022-01-01to2022-06-30">
<p id="xdx_80A_ecustom--SeniorConvertibleDebenturesAndWarrantsTextBlock_zh9Oik8s0Tee" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><span style="text-decoration: underline">Note 8 – <span id="xdx_828_zSj4E9OTNPL4">Senior Convertible Debentures and Warrants</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span id="xdx_90C_ecustom--SecuritiesPurchaseAgreementDescription_c20220301__20220331" title="Securities purchase agreement, description">In March 2022, the Company entered into a securities purchase agreement in which the Company maximum offering amount is $5,000,000. For every $1,000 invested in the offering, the Investors will receive a Debenture with a face amount of $1,000 and Warrants to purchase 350 Common Shares at an exercise price of $1.50 per share expiring on April 30, 2027.</span> Pursuant to this agreement, the Company has received proceeds from convertible debentures totaling $<span id="xdx_906_eus-gaap--ProceedsFromConvertibleDebt_pp0p0_c20220101__20220630__us-gaap--LongtermDebtTypeAxis__custom--ThreeConvertibleLoanDebenturesMember_z1ZroNvQbDn" title="Proceeds from convertible debentures">1,416,490</span> with an interest rate of <span id="xdx_907_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_dp_c20220630__us-gaap--LongtermDebtTypeAxis__custom--ThreeConvertibleLoanDebenturesMember_zwC99dBRrrP2" title="Interest rate">8</span>% maturing on <span id="xdx_906_eus-gaap--DebtInstrumentMaturityDate_dd_c20220101__20220630__us-gaap--LongtermDebtTypeAxis__custom--ThreeConvertibleLoanDebenturesMember_z9FMMy8wKP54" title="Maturity date">September 30, 2023</span>. Interest is due quarterly on January 1, April 1, July 1 and October 1 of each year during which the debentures are outstanding. Interest is payable in shares of the Company’s common stock until December 1, 2022. Thereafter, the interest will be paid 50% in cash and 50% in the Company’s common stock. The outstanding debentures are convertible into shares of common stock at $<span id="xdx_90C_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20220630_zm1yCPfyWmte" title="Price per share upon conversion of debentures">2.00</span> per share. The debentures may be converted at any time after the issuance date until the debentures are paid off.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company’s common stock underlying the convertible debentures and warrants is subject to a registration rights agreement. The Company is required to use its reasonable best efforts to comply with the provisions of the registration rights agreement.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company issued warrants to acquire up to an aggregate <span id="xdx_904_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20220630_zeQdmuShaZ78" title="Issuance of warrants">496,125</span> shares of the Company’s common stock at an exercise price ranging from $<span id="xdx_909_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20220630__srt--RangeAxis__srt--MinimumMember_z7s9eIWtt40f" title="Exercise price">0.75</span> to $<span id="xdx_907_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20220630__srt--RangeAxis__srt--MaximumMember_zVvj7B6oTjwc" title="Exercise price">1.50</span> per share. Each Warrant is exercisable by the Investor beginning on the effective date through the fifth-year anniversary thereof.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The fair value of each warrant issued during the six months ended June 30, 2022 was estimated on the date of issuance using the Black-Scholes option-pricing model with the following assumptions:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3pc; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_88D_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zKaKFeclgzg" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Senior Convertible Debentures and Warrants (Details)"> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span id="xdx_8BA_zyBXDcBePDoa" style="font-family: Times New Roman; font-size: 10pt"><b style="display: none">Schedule of assumptions</b></span></td> <td><span style="font-family: Times New Roman; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td style="width: 87%; text-align: justify"><span style="font-family: Times New Roman; font-size: 10pt">Stock price</span></td> <td style="width: 1%"><span style="font-family: Times New Roman; font-size: 10pt"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman; font-size: 10pt">$</span></td> <td id="xdx_981_eus-gaap--SharePrice_c20220630_pdd" style="width: 10%; text-align: right" title="Stock price"><span style="font-family: Times New Roman; font-size: 10pt">0.40</span></td> <td style="width: 1%"><span style="font-family: Times New Roman; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span style="font-family: Times New Roman; font-size: 10pt">Exercise price</span></td> <td><span style="font-family: Times New Roman; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman; font-size: 10pt">$</span></td> <td style="text-align: right"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_c20220630__srt--RangeAxis__srt--MinimumMember_zOpPGDrqZOl7" style="font-family: Times New Roman; font-size: 10pt">0.75 </span><span style="font-family: Times New Roman; font-size: 10pt">- <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_c20220630__srt--RangeAxis__srt--MaximumMember_zPTYz82csEFd">1.50</span></span></td> <td><span style="font-family: Times New Roman; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td style="text-align: justify"><span style="font-family: Times New Roman; font-size: 10pt">Risk-free interest rate</span></td> <td><span style="font-family: Times New Roman; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman; font-size: 10pt"> </span></td> <td style="text-align: right"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20220101__20220630__srt--RangeAxis__srt--MinimumMember_zS9ODgnSxJRj" style="font-family: Times New Roman; font-size: 10pt">2.10 </span><span style="font-family: Times New Roman; font-size: 10pt">- <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20220101__20220630__srt--RangeAxis__srt--MaximumMember_zz8WhQmARDHd">3.32</span></span></td> <td><span style="font-family: Times New Roman; font-size: 10pt">%</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span style="font-family: Times New Roman; font-size: 10pt">Expected dividend yield</span></td> <td><span style="font-family: Times New Roman; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman; font-size: 10pt"> </span></td> <td style="text-align: right"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp0_c20220101__20220630_z50ACsjLf6De" style="font-family: Times New Roman; font-size: 10pt">—</span></td> <td><span style="font-family: Times New Roman; font-size: 10pt">%</span></td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td style="text-align: justify"><span style="font-family: Times New Roman; font-size: 10pt">Expected stock volatility</span></td> <td><span style="font-family: Times New Roman; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman; font-size: 10pt"> </span></td> <td style="text-align: right"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20220101__20220630__srt--RangeAxis__srt--MinimumMember_zuVkoaUXhTi1" style="font-family: Times New Roman; font-size: 10pt">69.64 </span><span style="font-family: Times New Roman; font-size: 10pt">- <span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20220101__20220630__srt--RangeAxis__srt--MaximumMember_z5vyeiGLOccl">81.3</span></span></td> <td><span style="font-family: Times New Roman; font-size: 10pt">%</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span style="font-family: Times New Roman; font-size: 10pt">Expected life in years</span></td> <td><span style="font-family: Times New Roman; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman; font-size: 10pt"> </span></td> <td style="text-align: right"><span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20220630_zM5lRR7tDq6l" style="font-family: Times New Roman; font-size: 10pt">5.00</span></td> <td><span style="font-family: Times New Roman; font-size: 10pt"> 0</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The expected life was based on the average life of the warrants. Expected volatility is based on historical volatility of Company's common stock. The risk-free rate for periods within the contractual life of the warrants is based on the U.S. Treasury yield curve in effect at the time of issuance. The dividend yield assumption is based on the Company's expectation of dividend payments.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The fair value of the warrants was <span id="xdx_90C_ecustom--FairValueOfWarrants_pp0p0_c20220630_zYsT8POA2Kt2" title="Fair value of warrants">82,946</span>. During the six-month ended June 30, 2022, the Company amortized $<span id="xdx_90C_eus-gaap--AmortizationOfDebtDiscountPremium_pp0p0_c20220101__20220630_zqUxoXmFZH1d">5,925</span>, of the debt discount to interest expense.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p>
</mdxl:SeniorConvertibleDebenturesAndWarrantsTextBlock>
<mdxl:SecuritiesPurchaseAgreementDescription contextRef="From2022-03-012022-03-31"> In March 2022, the Company entered into a securities purchase agreement in which the Company maximum offering amount is $5,000,000. For every $1,000 invested in the offering, the Investors will receive a Debenture with a face amount of $1,000 and Warrants to purchase 350 Common Shares at an exercise price of $1.50 per share expiring on April 30, 2027. </mdxl:SecuritiesPurchaseAgreementDescription>
<us-gaap:ProceedsFromConvertibleDebt contextRef="From2022-01-012022-06-30_custom_ThreeConvertibleLoanDebenturesMember" decimals="0" unitRef="USD"> 1416490 </us-gaap:ProceedsFromConvertibleDebt>
<us-gaap:DebtInstrumentInterestRateEffectivePercentage contextRef="AsOf2022-06-30_custom_ThreeConvertibleLoanDebenturesMember" decimals="INF" unitRef="Pure"> 0.08 </us-gaap:DebtInstrumentInterestRateEffectivePercentage>
<us-gaap:DebtInstrumentMaturityDate contextRef="From2022-01-012022-06-30_custom_ThreeConvertibleLoanDebenturesMember"> 2023-09-30 </us-gaap:DebtInstrumentMaturityDate>
<us-gaap:DebtInstrumentConvertibleConversionPrice1 contextRef="AsOf2022-06-30" decimals="INF" unitRef="USDPShares"> 2.00 </us-gaap:DebtInstrumentConvertibleConversionPrice1>
<us-gaap:ClassOfWarrantOrRightOutstanding contextRef="AsOf2022-06-30" decimals="INF" unitRef="Shares"> 496125 </us-gaap:ClassOfWarrantOrRightOutstanding>
<us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2022-06-30_srt_MinimumMember" decimals="INF" unitRef="USDPShares"> 0.75 </us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
<us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2022-06-30_srt_MaximumMember" decimals="INF" unitRef="USDPShares"> 1.50 </us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
<us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="From2022-01-01to2022-06-30">
<table cellpadding="0" cellspacing="0" id="xdx_88D_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zKaKFeclgzg" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Senior Convertible Debentures and Warrants (Details)"> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span id="xdx_8BA_zyBXDcBePDoa" style="font-family: Times New Roman; font-size: 10pt"><b style="display: none">Schedule of assumptions</b></span></td> <td><span style="font-family: Times New Roman; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td style="width: 87%; text-align: justify"><span style="font-family: Times New Roman; font-size: 10pt">Stock price</span></td> <td style="width: 1%"><span style="font-family: Times New Roman; font-size: 10pt"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman; font-size: 10pt">$</span></td> <td id="xdx_981_eus-gaap--SharePrice_c20220630_pdd" style="width: 10%; text-align: right" title="Stock price"><span style="font-family: Times New Roman; font-size: 10pt">0.40</span></td> <td style="width: 1%"><span style="font-family: Times New Roman; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span style="font-family: Times New Roman; font-size: 10pt">Exercise price</span></td> <td><span style="font-family: Times New Roman; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman; font-size: 10pt">$</span></td> <td style="text-align: right"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_c20220630__srt--RangeAxis__srt--MinimumMember_zOpPGDrqZOl7" style="font-family: Times New Roman; font-size: 10pt">0.75 </span><span style="font-family: Times New Roman; font-size: 10pt">- <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_c20220630__srt--RangeAxis__srt--MaximumMember_zPTYz82csEFd">1.50</span></span></td> <td><span style="font-family: Times New Roman; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td style="text-align: justify"><span style="font-family: Times New Roman; font-size: 10pt">Risk-free interest rate</span></td> <td><span style="font-family: Times New Roman; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman; font-size: 10pt"> </span></td> <td style="text-align: right"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20220101__20220630__srt--RangeAxis__srt--MinimumMember_zS9ODgnSxJRj" style="font-family: Times New Roman; font-size: 10pt">2.10 </span><span style="font-family: Times New Roman; font-size: 10pt">- <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20220101__20220630__srt--RangeAxis__srt--MaximumMember_zz8WhQmARDHd">3.32</span></span></td> <td><span style="font-family: Times New Roman; font-size: 10pt">%</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span style="font-family: Times New Roman; font-size: 10pt">Expected dividend yield</span></td> <td><span style="font-family: Times New Roman; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman; font-size: 10pt"> </span></td> <td style="text-align: right"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp0_c20220101__20220630_z50ACsjLf6De" style="font-family: Times New Roman; font-size: 10pt">—</span></td> <td><span style="font-family: Times New Roman; font-size: 10pt">%</span></td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td style="text-align: justify"><span style="font-family: Times New Roman; font-size: 10pt">Expected stock volatility</span></td> <td><span style="font-family: Times New Roman; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman; font-size: 10pt"> </span></td> <td style="text-align: right"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20220101__20220630__srt--RangeAxis__srt--MinimumMember_zuVkoaUXhTi1" style="font-family: Times New Roman; font-size: 10pt">69.64 </span><span style="font-family: Times New Roman; font-size: 10pt">- <span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20220101__20220630__srt--RangeAxis__srt--MaximumMember_z5vyeiGLOccl">81.3</span></span></td> <td><span style="font-family: Times New Roman; font-size: 10pt">%</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span style="font-family: Times New Roman; font-size: 10pt">Expected life in years</span></td> <td><span style="font-family: Times New Roman; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman; font-size: 10pt"> </span></td> <td style="text-align: right"><span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20220630_zM5lRR7tDq6l" style="font-family: Times New Roman; font-size: 10pt">5.00</span></td> <td><span style="font-family: Times New Roman; font-size: 10pt"> 0</span></td></tr> </table>
</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
<us-gaap:SharePrice contextRef="AsOf2022-06-30" decimals="INF" unitRef="USDPShares"> 0.40 </us-gaap:SharePrice>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice contextRef="AsOf2022-06-30_srt_MinimumMember" decimals="INF" unitRef="USDPShares"> 0.75 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice contextRef="AsOf2022-06-30_srt_MaximumMember" decimals="INF" unitRef="USDPShares"> 1.50 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="From2022-01-012022-06-30_srt_MinimumMember" decimals="INF" unitRef="Pure"> 0.0210 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="From2022-01-012022-06-30_srt_MaximumMember" decimals="INF" unitRef="Pure"> 0.0332 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="From2022-01-01to2022-06-30" decimals="INF" unitRef="Pure"> 0 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="From2022-01-012022-06-30_srt_MinimumMember" decimals="INF" unitRef="Pure"> 0.6964 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="From2022-01-012022-06-30_srt_MaximumMember" decimals="INF" unitRef="Pure"> 0.813 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
<us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="From2022-01-01to2022-06-30"> P5Y </us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
<mdxl:FairValueOfWarrants contextRef="AsOf2022-06-30" decimals="0" unitRef="USD"> 82946 </mdxl:FairValueOfWarrants>
<us-gaap:AmortizationOfDebtDiscountPremium contextRef="From2022-01-01to2022-06-30" decimals="0" unitRef="USD"> 5925 </us-gaap:AmortizationOfDebtDiscountPremium>
</xbrl>

↑Top
Filing Submission 0001553350-22-000715   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Mon., May 13, 12:43:37.1pm ET